data_1wo6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1wo6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.737 0.304 . . . . 1.0 111.016 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.404 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 9.9 p -87.45 -27.61 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.02 -30.85 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -97.58 23.73 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.0 t -91.83 121.43 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.679 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.8 pt -96.76 35.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.441 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.72 132.86 24.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.763 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.02 -45.6 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.49 2.127 . . . . 0.0 112.371 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.72 66.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -94.43 -68.28 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.949 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.67 31.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.194 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.21 -47.71 26.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.04 28.86 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.09 27.8 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -80.98 145.23 31.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -100.33 -44.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.311 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.452 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.19 -27.13 5.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.0 -21.98 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.323 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.82 -49.9 10.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.867 0.365 . . . . 0.01 111.007 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.79 -26.96 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -49.87 -40.29 42.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.346 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.61 8.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.01 111.305 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 1.9 m -85.98 127.71 34.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.162 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -98.32 35.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.251 -0.881 . . . . 1.0 110.915 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.339 . . . . 1.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.413 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 10.6 p -80.53 -38.67 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.91 -31.34 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.55 -25.77 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 34.9 t -52.14 120.89 5.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.33 -26.08 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.32 125.61 43.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 -46.84 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.373 2.048 . . . . 0.0 112.353 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -87.53 55.41 3.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.84 30.31 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.98 65.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.981 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.07 29.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 57.41 28.07 14.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -111.76 150.57 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.115 0.483 . . . . 0.0 111.041 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.21 -44.05 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.272 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.97 -27.73 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.89 -24.01 17.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.16 -47.81 17.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.01 110.797 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.9 t -46.39 -26.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -50.17 -40.44 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 111.251 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.01 -36.69 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.01 111.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.523 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.8 m -86.78 -176.14 5.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -163.35 31.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 1.0 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.408 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 10.3 p -85.39 -28.96 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -60.03 -32.35 70.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.733 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -100.39 26.77 6.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.84 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.2 t -87.13 107.59 18.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.68 30.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.26 102.01 53.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.31 62.11 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.382 2.055 . . . . 0.0 112.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -178.71 36.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 17.3 m -116.19 -23.11 8.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.8 92.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.808 0.337 . . . . 0.0 111.358 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.71 -46.23 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.965 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.9 24.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.7 29.33 9.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.325 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -105.55 146.4 29.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.484 . . . . 0.0 111.14 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -100.24 -44.78 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.227 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.39 -27.52 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.83 -23.19 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.31 -49.77 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.01 110.896 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.486 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.2 t -46.03 -26.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 t -49.64 -40.43 39.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.23 -36.9 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.01 111.142 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.4 m -85.88 126.34 33.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.157 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.11 39.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.856 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.778 0.323 . . . . 1.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p 43.85 30.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.506 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.89 -45.38 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -84.96 -18.63 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.856 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.7 t -51.07 115.44 1.54 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -97.22 34.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -133.68 90.77 27.29 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.01 62.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -176.31 36.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -98.66 -58.49 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.39 158.65 22.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.38 13.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.13 28.62 8.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.9 29.31 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.197 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -80.02 143.73 33.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.23 -43.04 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.305 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.77 -27.35 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.214 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -21.85 17.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.224 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.88 -52.93 6.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.01 110.964 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.489 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.1 t -45.73 -27.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.9 t -49.66 -40.43 39.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.98 -36.15 8.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.01 111.286 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -85.92 135.63 33.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.221 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -111.04 31.58 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 1.0 110.886 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.781 0.324 . . . . 1.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p -106.05 -23.88 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.5 -29.13 61.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -106.91 24.07 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 8.1 t -86.67 112.53 21.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -75.9 -31.53 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.73 110.62 2.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.78 -57.45 2.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.493 2.129 . . . . 0.0 112.392 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -124.42 95.65 4.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 28.6 p -115.51 -40.68 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 -167.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.8 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.086 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.55 30.35 3.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.54 58.31 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -79.89 147.1 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.195 0.521 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.29 -44.92 11.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.405 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.94 -12.36 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.572 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.08 13.54 10.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -90.21 -53.84 4.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.81 0.338 . . . . 0.01 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.2 t -46.39 -26.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.3 t -49.89 -40.6 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.16 -35.5 8.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.509 . . . . 0.01 111.157 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.83 179.45 6.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.57 35.71 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.187 -0.911 . . . . 1.0 110.993 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.849 0.357 . . . . 1.0 111.031 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.413 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 11.9 p -100.55 -27.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -32.19 62.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.49 -24.03 21.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.6 t -53.11 127.31 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.881 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.8 pt -84.8 -30.2 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 126.5 78.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.5 -45.08 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.46 2.107 . . . . 0.0 112.339 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -105.38 75.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.406 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -108.78 -33.92 6.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.54 152.22 46.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 25.43 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.39 34.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.79 27.89 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.349 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -80.05 132.6 36.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.046 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 1.4 t -100.14 -48.05 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.883 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.17 -28.22 4.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.24 -24.3 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.172 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.42 -49.81 11.78 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.856 0.36 . . . . 0.01 110.859 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.24 -26.86 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 t -50.08 -40.07 44.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 0.0 111.342 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.66 8.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.01 111.121 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.15 133.29 33.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.156 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -114.03 31.41 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.931 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.878 0.37 . . . . 1.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.5 -38.92 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -32.67 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 -24.67 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.0 t -52.34 119.37 4.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -96.84 35.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 tt -133.19 94.45 20.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.87 53.67 4.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.602 2.202 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.1 37.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 21.6 p -111.02 -41.1 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.795 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.1 -166.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.62 -43.89 1.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.11 28.07 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.43 35.76 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.231 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -79.82 153.3 29.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.469 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.27 -45.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -66.2 -24.36 66.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.247 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.9 -4.3 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.743 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -84.71 -53.13 5.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.744 0.306 . . . . 0.01 110.766 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 1.6 t -46.41 -26.56 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.638 0.256 . . . . 0.0 111.666 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 t -50.87 -40.21 55.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.449 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.74 -32.59 9.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.01 111.257 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.7 m -90.58 -178.53 5.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.185 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.05 35.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 mttp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.272 -0.871 . . . . 1.0 110.885 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.794 0.33 . . . . 1.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.408 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 9.9 p -99.59 -29.61 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -55.9 -32.41 63.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.709 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -88.07 -24.84 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.787 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 40.7 t -53.87 114.54 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pp -97.54 35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.16 140.36 21.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 95.59 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 112.269 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 60.1 69.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -59.41 -70.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.3 -29.27 9.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.05 14.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.24 20.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.265 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.61 26.79 4.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.379 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -107.35 130.94 54.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.213 0.53 . . . . 0.0 111.013 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 1.3 t -100.21 -47.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.889 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.44 -28.01 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.05 -24.31 19.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.8 -50.57 11.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.902 0.382 . . . . 0.01 110.895 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.3 t -45.94 -27.02 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 t -49.62 -40.27 38.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 111.363 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.47 -36.68 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.01 111.186 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.7 m -85.93 132.57 34.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.18 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.53 32.42 4.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 mttp . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.891 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.799 0.333 . . . . 1.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.67 -33.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -31.07 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.655 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -84.59 -25.46 28.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 33.0 t -53.44 133.58 40.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 pt -97.07 -36.09 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tt -54.99 108.12 1.07 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.03 44.87 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.658 2.238 . . . . 0.0 112.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 176.76 39.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 18.2 p -99.97 -40.14 7.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.53 -168.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.75 -57.59 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.81 30.92 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.22 47.38 11.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -79.88 148.32 31.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.28 -44.96 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.289 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.86 -25.28 61.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.188 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.89 3.63 39.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.726 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -87.82 -53.39 4.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.01 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.6 t -46.51 -26.65 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.634 0.254 . . . . 0.0 111.68 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.4 t -50.31 -40.52 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 111.361 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.69 -33.96 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.01 111.141 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.81 -177.7 5.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.199 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -145.33 31.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 1.0 110.929 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.411 ' CA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.798 0.332 . . . . 1.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p 43.5 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.494 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.54 -45.23 3.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -94.64 14.92 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.081 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 42.0 t -63.81 -62.21 1.79 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt 42.3 30.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.831 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -98.79 138.26 20.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.17 90.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.404 2.069 . . . . 0.0 112.256 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 62.38 117.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -72.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.51 17.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.098 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.2 23.62 7.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -170.26 32.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.167 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 51.24 26.75 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.394 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -80.02 140.29 36.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.128 0.489 . . . . 0.0 111.07 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.36 -44.39 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.366 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.25 -27.11 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.349 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.79 -20.76 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.0 -54.53 4.99 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.875 0.369 . . . . 0.01 110.987 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.4 t -45.6 -27.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -49.86 -40.08 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.88 0.371 . . . . 0.0 111.369 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.95 -35.48 8.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.01 111.358 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.0 m -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -111.29 31.28 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mttp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.874 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.814 0.34 . . . . 1.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.93 -24.07 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -30.77 63.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -100.56 26.69 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 21.1 t -89.53 113.73 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.656 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 pp -96.59 35.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tt -138.88 91.75 11.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.771 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.77 54.78 4.13 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.535 2.157 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 tttt 174.22 39.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -107.02 -40.58 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.66 -175.67 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.1 -38.28 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.5 29.2 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.24 50.87 9.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -79.96 144.01 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.807 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.32 -44.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.437 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -72.77 -22.48 60.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.325 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.46 10.47 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.717 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -93.88 -56.23 2.95 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.813 0.339 . . . . 0.01 110.903 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.9 t -45.84 -26.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.0 t -49.97 -40.5 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -104.64 -33.12 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.01 111.281 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.545 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.82 177.35 6.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.226 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -142.98 33.61 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 1.0 110.941 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.329 . . . . 1.0 110.992 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p 43.96 30.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.636 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -95.31 -41.73 8.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.56 25.45 6.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.754 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.4 t -80.66 97.9 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 pp -96.97 35.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.251 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.47 119.73 48.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.762 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.42 -28.15 34.34 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -168.26 86.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.423 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 30.4 p -95.41 -40.93 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.64 -40.92 2.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.81 29.94 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.139 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.13 14.81 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.0 25.61 3.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.685 0.279 . . . . 0.0 111.475 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.16 135.54 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.42 -44.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.413 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.75 -25.22 61.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.88 6.88 36.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.784 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -91.33 -54.87 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.835 0.35 . . . . 0.01 110.898 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.478 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.19 -26.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -49.6 -40.61 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.345 . . . . 0.0 111.371 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -103.62 -35.48 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.507 . . . . 0.01 111.213 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -86.24 178.2 7.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.173 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -156.83 32.3 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.253 -0.88 . . . . 1.0 110.942 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 1.0 111.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.7 p 44.25 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.594 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.64 -44.64 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -98.65 23.37 8.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 30.7 t -72.94 78.88 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 pt -60.46 -29.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 109.42 1.71 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.2 -47.48 26.6 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -133.18 97.32 3.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 28.7 p -113.79 -40.5 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 -46.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.98 47.04 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 13.13 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.83 24.68 3.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.511 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -106.15 142.24 36.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.869 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.34 -45.38 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.397 -179.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -62.17 -25.23 67.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.182 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.65 -10.71 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.604 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.589 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -84.03 -55.98 3.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.853 0.358 . . . . 0.01 110.979 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.488 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.94 -26.89 0.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -49.44 -40.41 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -104.09 -35.21 8.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.079 -0.509 . . . . 0.01 111.247 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.24 126.09 34.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.139 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -97.09 39.28 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.892 . . . . 1.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.452 ' CB ' ' CE1' ' A' ' 4' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 1.0 110.956 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p -94.12 -28.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -58.61 -30.38 67.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 1' ' ' ALA . 1.7 p90 -125.76 23.07 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.19 93.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.369 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.3 -42.96 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.375 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.47 107.81 0.95 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.108 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.488 2.125 . . . . 0.0 112.344 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 59.91 64.52 1.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.987 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 p -89.87 -30.54 17.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.06 -45.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.26 66.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.92 14.32 2.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.395 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.31 23.33 4.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.618 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -117.39 140.76 49.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.44 -45.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -59.07 -28.38 66.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.51 -17.81 22.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.603 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.89 -50.64 10.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.851 0.358 . . . . 0.01 110.813 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.5 t -46.96 -26.01 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -51.38 -39.68 57.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.37 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.13 -35.53 8.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.01 111.195 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.75 174.21 8.97 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.144 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.73 45.53 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.189 -0.91 . . . . 1.0 110.953 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.409 ' CA ' ' CG2' ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.792 0.329 . . . . 1.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p 43.97 30.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.721 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.25 -59.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.09 -18.89 60.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.7 t -50.38 130.13 22.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.017 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 pt -138.76 29.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.4 tt -83.67 137.61 41.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.65 85.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.437 2.091 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 55.34 83.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.429 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 21.3 p -90.96 -40.48 11.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.25 -167.03 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.63 -46.36 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.32 31.54 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.26 53.59 5.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -79.81 145.17 32.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -100.3 -43.77 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.344 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.89 -18.25 60.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.21 11.3 17.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.781 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -90.78 -55.64 3.49 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.814 0.34 . . . . 0.01 110.81 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.479 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 3.5 t -46.32 -26.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.7 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -49.92 -40.6 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 0.0 111.303 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.72 -34.66 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.01 111.167 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -87.14 179.34 6.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.272 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.94 31.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.877 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.856 0.36 . . . . 1.0 111.011 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p 44.24 30.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.734 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.74 -44.32 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -98.72 26.59 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.73 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 45.0 t -73.78 66.82 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.82 -23.0 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.437 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.56 138.5 60.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.05 87.35 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.371 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mttp 59.14 65.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -60.74 -40.28 91.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 -47.18 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.34 71.85 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.6 25.86 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.53 23.88 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -99.55 125.46 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -100.29 -63.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.038 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.07 -26.59 27.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.58 -12.07 30.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.601 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.96 -55.23 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 0.01 110.865 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.8 t -45.65 -26.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -49.21 -40.52 33.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER -103.63 -35.6 8.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.01 111.221 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.9 m -85.99 128.6 34.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.185 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -98.71 31.57 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.209 -0.9 . . . . 1.0 110.883 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.406 ' CA ' ' CG2' ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.8 0.333 . . . . 1.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p 44.01 30.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.7 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.586 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -75.76 -20.05 58.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.915 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.7 t -51.82 109.81 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.5 pt -97.72 30.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.053 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.55 93.18 48.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 53.18 4.11 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.529 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tttm 177.39 38.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 20.6 p -106.84 -41.3 5.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.06 -168.11 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.06 -39.31 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.35 48.57 1.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.0 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -79.94 143.75 33.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -100.27 -43.87 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.346 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -73.83 -21.89 59.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.327 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.54 9.49 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.667 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -91.89 -56.42 3.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.779 0.323 . . . . 0.01 110.814 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.495 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.12 -26.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -50.11 -40.4 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.362 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.43 -33.52 8.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.01 111.25 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.538 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -88.4 179.9 6.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.211 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.71 31.79 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.19 -0.909 . . . . 1.0 110.89 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.746 0.308 . . . . 1.0 111.067 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.47 -34.35 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.17 -31.5 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.666 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.28 22.17 11.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.2 t -85.38 110.22 18.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.596 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 pp -96.14 34.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.18 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.95 82.42 49.15 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.806 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.73 57.09 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.901 2.401 . . . . 0.0 112.345 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.99 38.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.676 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -108.97 -40.32 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.88 -175.11 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.43 36.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.99 10.27 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.537 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.57 25.49 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.805 0.336 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -104.18 151.22 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.16 0.505 . . . . 0.0 110.938 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -100.27 -45.38 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.294 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -54.97 -24.46 24.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.13 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.68 -17.82 16.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.383 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.43 -53.44 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.807 0.337 . . . . 0.01 110.856 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.38 -26.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -51.23 -39.85 57.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 111.366 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.18 -33.45 8.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.01 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.5 m -89.0 139.1 30.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.153 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -95.37 44.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.943 179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.822 0.344 . . . . 1.0 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.56 -24.17 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -55.25 -32.31 62.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -101.82 24.75 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 19.0 t -82.5 102.33 11.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 pt -76.41 -4.86 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.57 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -106.06 92.79 6.94 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.3 53.64 4.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.585 2.19 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm 175.78 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 29.2 p -102.19 -40.8 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.52 -174.5 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.44 30.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.174 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.91 22.42 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.54 27.68 6.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.435 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -80.77 133.59 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.328 0.585 . . . . 0.0 110.944 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -100.15 -63.74 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.81 -29.18 59.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.36 -9.9 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.442 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.612 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.83 -53.34 6.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.802 0.334 . . . . 0.01 110.784 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.494 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.1 t -46.3 -26.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -50.88 -39.94 55.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.399 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.97 -33.63 8.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.01 111.233 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.0 m -88.79 177.77 6.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.57 37.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.278 -0.868 . . . . 1.0 110.868 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.406 ' CA ' ' CG2' ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.808 0.337 . . . . 1.0 111.007 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p 44.04 30.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.603 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -56.04 3.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.551 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -89.31 7.81 33.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.1 t -60.16 109.35 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 pt -97.09 31.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 tt -141.01 87.42 10.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.702 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 -26.8 75.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.511 2.141 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.89 42.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 15.4 p -106.67 -40.71 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.05 -166.52 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 -47.06 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.233 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.1 43.19 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.45 41.25 16.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.78 143.46 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.25 -43.81 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.439 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.47 59.0 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.018 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 166.5 -31.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.824 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -49.99 -50.57 46.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.45 . . . . 0.01 111.161 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.47 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.5 t -46.77 -26.13 0.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -51.95 -38.96 58.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 0.0 111.489 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.91 -33.92 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.01 111.226 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.2 m -88.9 176.45 7.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.214 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.65 34.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.881 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.737 0.304 . . . . 1.0 111.016 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.404 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 9.9 p -87.45 -27.61 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.02 -30.85 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -97.58 23.73 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.0 t -91.83 121.43 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.679 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.8 pt -96.76 35.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.441 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.72 132.86 24.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.763 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.02 -45.6 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.49 2.127 . . . . 0.0 112.371 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.72 66.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -94.43 -68.28 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.949 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -99.03 141.67 31.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.194 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.21 -47.71 26.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.04 28.86 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.09 27.8 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -80.98 145.23 31.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -100.33 -44.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.311 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.452 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.19 -27.13 5.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.0 -21.98 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.323 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.82 -49.9 10.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.867 0.365 . . . . 0.01 111.007 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.79 -26.96 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -49.87 -40.29 42.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.346 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.61 8.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.01 111.305 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 1.9 m -85.98 127.71 34.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.162 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -98.32 35.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.251 -0.881 . . . . 1.0 110.915 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.339 . . . . 1.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.413 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 10.6 p -80.53 -38.67 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.91 -31.34 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.55 -25.77 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 34.9 t -52.14 120.89 5.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.33 -26.08 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.32 125.61 43.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 -46.84 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.373 2.048 . . . . 0.0 112.353 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -87.53 55.41 3.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.84 30.31 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.98 65.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.981 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -161.07 29.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 57.41 28.07 14.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -111.76 150.57 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.115 0.483 . . . . 0.0 111.041 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.21 -44.05 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.272 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.97 -27.73 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -94.89 -24.01 17.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.16 -47.81 17.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.01 110.797 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.9 t -46.39 -26.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -50.17 -40.44 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 111.251 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.01 -36.69 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.01 111.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.523 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.8 m -86.78 -176.14 5.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -163.35 31.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 1.0 110.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 10.3 p -85.39 -28.96 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -60.03 -32.35 70.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.733 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -100.39 26.77 6.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.84 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.2 t -87.13 107.59 18.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.68 30.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.26 102.01 53.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.31 62.11 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.382 2.055 . . . . 0.0 112.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -178.71 36.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 17.3 m -116.19 -23.11 8.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.8 92.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.808 0.337 . . . . 0.0 111.358 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.71 -46.23 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.965 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -152.9 24.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.256 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.7 29.33 9.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.325 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -105.55 146.4 29.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.484 . . . . 0.0 111.14 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -100.24 -44.78 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.227 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.39 -27.52 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.83 -23.19 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.31 -49.77 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.01 110.896 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.486 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.2 t -46.03 -26.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 t -49.64 -40.43 39.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.23 -36.9 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.01 111.142 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.4 m -85.88 126.34 33.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.157 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.11 39.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.856 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.778 0.323 . . . . 1.0 111.055 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.6 p 43.85 30.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.506 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.89 -45.38 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -84.96 -18.63 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.856 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.7 t -51.07 115.44 1.54 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.6 pp -97.22 34.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -133.68 90.77 27.29 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.01 62.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -176.31 36.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -98.66 -58.49 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.39 158.65 22.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.38 13.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.13 28.62 8.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.9 29.31 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.197 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -80.02 143.73 33.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 110.931 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.441 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.23 -43.04 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.305 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.77 -27.35 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.214 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -21.85 17.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.224 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.88 -52.93 6.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.01 110.964 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.489 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.1 t -45.73 -27.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.9 t -49.66 -40.43 39.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.98 -36.15 8.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.01 111.286 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -85.92 135.63 33.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.221 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -111.04 31.58 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 1.0 110.886 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.781 0.324 . . . . 1.0 111.03 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.3 p -106.05 -23.88 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.5 -29.13 61.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -106.91 24.07 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 8.1 t -86.67 112.53 21.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -75.9 -31.53 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.9 tt -59.73 110.62 2.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.78 -57.45 2.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.493 2.129 . . . . 0.0 112.392 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -124.42 95.65 4.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.415 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 28.6 p -115.51 -40.68 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 -167.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.8 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.086 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.55 30.35 3.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.54 58.31 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -79.89 147.1 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.195 0.521 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.29 -44.92 11.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.405 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.94 -12.36 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.572 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.08 13.54 10.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -90.21 -53.84 4.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.81 0.338 . . . . 0.01 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.2 t -46.39 -26.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.3 t -49.89 -40.6 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.334 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.16 -35.5 8.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.509 . . . . 0.01 111.157 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.83 179.45 6.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.57 35.71 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.187 -0.911 . . . . 1.0 110.993 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.849 0.357 . . . . 1.0 111.031 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.413 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 11.9 p -100.55 -27.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -32.19 62.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.49 -24.03 21.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.6 t -53.11 127.31 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.881 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.8 pt -84.8 -30.2 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 126.5 78.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.5 -45.08 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.46 2.107 . . . . 0.0 112.339 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -105.38 75.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.406 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -108.78 -33.92 6.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.54 152.22 46.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 25.43 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.39 34.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.79 27.89 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.349 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -80.05 132.6 36.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.046 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.413 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 1.4 t -100.14 -48.05 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.883 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.17 -28.22 4.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.24 -24.3 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.172 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.42 -49.81 11.78 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.856 0.36 . . . . 0.01 110.859 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.24 -26.86 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.4 t -50.08 -40.07 44.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 0.0 111.342 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.66 8.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.01 111.121 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.15 133.29 33.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.156 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -114.03 31.41 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.931 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.878 0.37 . . . . 1.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.8 p -94.5 -38.92 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.023 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -32.67 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 -24.67 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.0 t -52.34 119.37 4.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -96.84 35.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.6 tt -133.19 94.45 20.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.87 53.67 4.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.602 2.202 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.1 37.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.452 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 21.6 p -111.02 -41.1 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.795 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.1 -166.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.62 -43.89 1.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.11 28.07 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.43 35.76 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.231 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -79.82 153.3 29.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.469 . . . . 0.0 110.985 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.27 -45.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -66.2 -24.36 66.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.247 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.9 -4.3 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.743 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -84.71 -53.13 5.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.744 0.306 . . . . 0.01 110.766 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 1.6 t -46.41 -26.56 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.638 0.256 . . . . 0.0 111.666 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 t -50.87 -40.21 55.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.449 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.74 -32.59 9.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.01 111.257 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.7 m -90.58 -178.53 5.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.185 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.05 35.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 mttp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.272 -0.871 . . . . 1.0 110.885 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.794 0.33 . . . . 1.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.408 ' N ' ' CG2' ' A' ' 16' ' ' VAL . 9.9 p -99.59 -29.61 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -55.9 -32.41 63.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.709 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -88.07 -24.84 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.787 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 40.7 t -53.87 114.54 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 pp -97.54 35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.16 140.36 21.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -70.34 95.59 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 112.269 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 60.1 69.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -59.41 -70.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.3 -29.27 9.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.05 14.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -146.24 20.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.265 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.61 26.79 4.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.379 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -107.35 130.94 54.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.213 0.53 . . . . 0.0 111.013 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.408 ' CG2' ' N ' ' A' ' 2' ' ' VAL . 1.3 t -100.21 -47.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.889 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.44 -28.01 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.05 -24.31 19.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.8 -50.57 11.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.902 0.382 . . . . 0.01 110.895 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.3 t -45.94 -27.02 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.0 t -49.62 -40.27 38.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 111.363 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.47 -36.68 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.01 111.186 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.7 m -85.93 132.57 34.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.18 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.53 32.42 4.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 mttp . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.891 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.799 0.333 . . . . 1.0 111.028 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -105.67 -33.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -31.07 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.655 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -84.59 -25.46 28.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 33.0 t -53.44 133.58 40.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 pt -97.07 -36.09 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 2.0 tt -54.99 108.12 1.07 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.03 44.87 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.658 2.238 . . . . 0.0 112.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 176.76 39.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 18.2 p -99.97 -40.14 7.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.53 -168.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.75 -57.59 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.81 30.92 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.22 47.38 11.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -79.88 148.32 31.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -100.28 -44.96 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.289 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.86 -25.28 61.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.188 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -101.89 3.63 39.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.726 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -87.82 -53.39 4.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.01 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.6 t -46.51 -26.65 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.634 0.254 . . . . 0.0 111.68 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.4 t -50.31 -40.52 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 111.361 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.69 -33.96 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.01 111.141 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.81 -177.7 5.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.199 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -145.33 31.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 1.0 110.929 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.411 ' CA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.798 0.332 . . . . 1.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 13.9 p 43.5 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.494 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.54 -45.23 3.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -94.64 14.92 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.081 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.435 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 42.0 t -63.81 -62.21 1.79 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt 42.3 30.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.831 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -98.79 138.26 20.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.17 90.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.404 2.069 . . . . 0.0 112.256 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 62.38 117.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -72.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.48 154.51 17.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.098 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.2 23.62 7.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -170.26 32.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.167 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 51.24 26.75 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.394 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -80.02 140.29 36.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.128 0.489 . . . . 0.0 111.07 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.36 -44.39 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.366 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.25 -27.11 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.349 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.79 -20.76 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.0 -54.53 4.99 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.875 0.369 . . . . 0.01 110.987 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.4 t -45.6 -27.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.5 t -49.86 -40.08 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.88 0.371 . . . . 0.0 111.369 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.95 -35.48 8.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.01 111.358 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.0 m -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -111.29 31.28 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mttp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.874 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.814 0.34 . . . . 1.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.2 p -100.93 -24.07 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -30.77 63.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -100.56 26.69 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.434 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 21.1 t -89.53 113.73 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.656 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 pp -96.59 35.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.7 tt -138.88 91.75 11.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.771 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.77 54.78 4.13 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.535 2.157 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 tttt 174.22 39.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -107.02 -40.58 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.66 -175.67 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.1 -38.28 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.5 29.2 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.24 50.87 9.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -79.96 144.01 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.807 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.32 -44.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.437 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -72.77 -22.48 60.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.325 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.46 10.47 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.717 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -93.88 -56.23 2.95 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.813 0.339 . . . . 0.01 110.903 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.9 t -45.84 -26.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.0 t -49.97 -40.5 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -104.64 -33.12 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.01 111.281 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.545 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.82 177.35 6.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.226 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -142.98 33.61 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 1.0 110.941 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.329 . . . . 1.0 110.992 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p 43.96 30.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.636 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -95.31 -41.73 8.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.56 25.45 6.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.754 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.4 t -80.66 97.9 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 pp -96.97 35.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.251 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.47 119.73 48.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.762 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.42 -28.15 34.34 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -168.26 86.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.423 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 30.4 p -95.41 -40.93 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.64 -40.92 2.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.81 29.94 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.139 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -139.13 14.81 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.402 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.0 25.61 3.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.685 0.279 . . . . 0.0 111.475 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -85.16 135.54 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.917 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.451 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.42 -44.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.413 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.75 -25.22 61.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.88 6.88 36.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.784 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -91.33 -54.87 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.835 0.35 . . . . 0.01 110.898 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.478 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.19 -26.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -49.6 -40.61 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.345 . . . . 0.0 111.371 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -103.62 -35.48 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.507 . . . . 0.01 111.213 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -86.24 178.2 7.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.173 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -156.83 32.3 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.253 -0.88 . . . . 1.0 110.942 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 1.0 111.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.7 p 44.25 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.594 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.64 -44.64 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -98.65 23.37 8.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 30.7 t -72.94 78.88 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 pt -60.46 -29.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.03 109.42 1.71 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.2 -47.48 26.6 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -133.18 97.32 3.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.416 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 28.7 p -113.79 -40.5 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 -46.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.98 47.04 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -136.92 13.13 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.83 24.68 3.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.511 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -106.15 142.24 36.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.869 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.34 -45.38 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.397 -179.289 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -62.17 -25.23 67.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.182 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -99.65 -10.71 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.604 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.589 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -84.03 -55.98 3.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.853 0.358 . . . . 0.01 110.979 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.488 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.94 -26.89 0.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 t -49.44 -40.41 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -104.09 -35.21 8.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.079 -0.509 . . . . 0.01 111.247 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.24 126.09 34.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.139 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -97.09 39.28 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.892 . . . . 1.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' CB ' ' CE1' ' A' ' 4' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 1.0 110.956 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p -94.12 -28.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -58.61 -30.38 67.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 1' ' ' ALA . 1.7 p90 -125.76 23.07 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.19 93.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.369 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.7 pp -57.3 -42.96 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.375 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.5 tt -53.47 107.81 0.95 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.108 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.488 2.125 . . . . 0.0 112.344 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 59.91 64.52 1.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.987 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 31.3 p -89.87 -30.54 17.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.818 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -154.06 -45.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.26 66.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -138.92 14.32 2.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.395 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.31 23.33 4.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.618 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -117.39 140.76 49.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.8 OUTLIER -100.44 -45.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -59.07 -28.38 66.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.51 -17.81 22.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.603 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.89 -50.64 10.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.851 0.358 . . . . 0.01 110.813 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.5 t -46.96 -26.01 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.2 t -51.38 -39.68 57.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.37 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.13 -35.53 8.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.01 111.195 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.75 174.21 8.97 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.144 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.73 45.53 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.189 -0.91 . . . . 1.0 110.953 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.409 ' CA ' ' CG2' ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.792 0.329 . . . . 1.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 p 43.97 30.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.721 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.25 -59.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.09 -18.89 60.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.7 t -50.38 130.13 22.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.017 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 pt -138.76 29.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.4 tt -83.67 137.61 41.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -55.65 85.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.437 2.091 . . . . 0.0 112.359 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 55.34 83.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.429 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 21.3 p -90.96 -40.48 11.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.25 -167.03 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.63 -46.36 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.32 31.54 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.26 53.59 5.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -79.81 145.17 32.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -100.3 -43.77 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.344 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.89 -18.25 60.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.21 11.3 17.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.781 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -90.78 -55.64 3.49 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.814 0.34 . . . . 0.01 110.81 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.479 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 3.5 t -46.32 -26.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.7 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.5 t -49.92 -40.6 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 0.0 111.303 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.72 -34.66 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.01 111.167 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -87.14 179.34 6.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.272 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.94 31.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.877 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.856 0.36 . . . . 1.0 111.011 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p 44.24 30.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.734 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.74 -44.32 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -98.72 26.59 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.73 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 45.0 t -73.78 66.82 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.82 -23.0 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.437 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -54.56 138.5 60.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.05 87.35 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.371 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mttp 59.14 65.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.2 p -60.74 -40.28 91.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 -47.18 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.34 71.85 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -154.6 25.86 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.53 23.88 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -99.55 125.46 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -100.29 -63.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.038 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.07 -26.59 27.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -93.58 -12.07 30.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.601 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.96 -55.23 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 0.01 110.865 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.8 t -45.65 -26.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.3 t -49.21 -40.52 33.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER -103.63 -35.6 8.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.01 111.221 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.9 m -85.99 128.6 34.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.185 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -98.71 31.57 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.209 -0.9 . . . . 1.0 110.883 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' CA ' ' CG2' ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.8 0.333 . . . . 1.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 p 44.01 30.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.7 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.586 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -75.76 -20.05 58.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.915 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.7 t -51.82 109.81 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.5 pt -97.72 30.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.053 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.3 tt -121.55 93.18 48.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 53.18 4.11 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.529 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tttm 177.39 38.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 20.6 p -106.84 -41.3 5.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.06 -168.11 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.06 -39.31 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.35 48.57 1.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.0 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -79.94 143.75 33.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -100.27 -43.87 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.346 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -73.83 -21.89 59.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.327 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.54 9.49 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.667 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -91.89 -56.42 3.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.779 0.323 . . . . 0.01 110.814 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.495 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.12 -26.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.9 t -50.11 -40.4 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.362 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.43 -33.52 8.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.01 111.25 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.538 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -88.4 179.9 6.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.211 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.71 31.79 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.19 -0.909 . . . . 1.0 110.89 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.746 0.308 . . . . 1.0 111.067 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.8 p -79.47 -34.35 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.17 -31.5 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.666 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.28 22.17 11.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.2 t -85.38 110.22 18.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.596 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.7 pp -96.14 34.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.18 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.0 tt -133.95 82.42 49.15 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.806 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.73 57.09 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.901 2.401 . . . . 0.0 112.345 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.99 38.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.676 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -108.97 -40.32 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.88 -175.11 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.43 36.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -133.99 10.27 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.537 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.57 25.49 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.805 0.336 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -104.18 151.22 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.16 0.505 . . . . 0.0 110.938 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -100.27 -45.38 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.294 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -54.97 -24.46 24.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.13 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -100.68 -17.82 16.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.383 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.43 -53.44 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.807 0.337 . . . . 0.01 110.856 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.38 -26.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 t -51.23 -39.85 57.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 111.366 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.18 -33.45 8.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.01 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.5 m -89.0 139.1 30.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.153 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -95.37 44.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.943 179.978 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.822 0.344 . . . . 1.0 111.088 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -94.56 -24.17 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -55.25 -32.31 62.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -101.82 24.75 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.429 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 19.0 t -82.5 102.33 11.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 pt -76.41 -4.86 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.57 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -106.06 92.79 6.94 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.3 53.64 4.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.585 2.19 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm 175.78 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 29.2 p -102.19 -40.8 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.52 -174.5 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.44 30.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.174 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.91 22.42 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.54 27.68 6.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.435 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.2 p30 -80.77 133.59 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.328 0.585 . . . . 0.0 110.944 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.4 t -100.15 -63.74 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.979 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.81 -29.18 59.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.36 -9.9 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.442 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.612 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.83 -53.34 6.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.802 0.334 . . . . 0.01 110.784 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.494 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.1 t -46.3 -26.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.5 t -50.88 -39.94 55.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.399 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.97 -33.63 8.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.01 111.233 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.0 m -88.79 177.77 6.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.57 37.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.278 -0.868 . . . . 1.0 110.868 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.406 ' CA ' ' CG2' ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.808 0.337 . . . . 1.0 111.007 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p 44.04 30.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.603 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -56.04 3.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.551 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -89.31 7.81 33.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.1 t -60.16 109.35 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 pt -97.09 31.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.4 tt -141.01 87.42 10.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.702 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 -26.8 75.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.511 2.141 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -96.89 42.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 15.4 p -106.67 -40.71 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.05 -166.52 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 -47.06 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.233 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.1 43.19 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.45 41.25 16.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.78 143.46 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 17' ' ' ALA . 0.5 OUTLIER -100.25 -43.81 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.439 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.47 59.0 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.018 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . 166.5 -31.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.824 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -49.99 -50.57 46.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.45 . . . . 0.01 111.161 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.47 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.5 t -46.77 -26.13 0.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 t -51.95 -38.96 58.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 0.0 111.489 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.91 -33.92 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.01 111.226 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.2 m -88.9 176.45 7.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.214 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.65 34.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.881 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.737 0.304 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.9 p -87.45 -27.61 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.02 -30.85 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -97.58 23.73 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.0 t -91.83 121.43 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.679 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.8 pt -96.76 35.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.441 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.646 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -120.72 132.86 24.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.763 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.646 ' HD2' HD23 ' A' ' 7' ' ' LEU . 60.7 Cg_endo -73.02 -45.6 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.49 2.127 . . . . 0.0 112.371 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.72 66.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.43 -68.28 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.949 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -99.03 141.67 31.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.194 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.21 -47.71 26.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.04 28.86 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.09 27.8 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.789 ' OD1' ' HB1' ' A' ' 11' ' ' ALA . 21.7 p-10 -80.98 145.23 31.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.33 -44.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.311 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.452 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.19 -27.13 5.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.0 -21.98 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.323 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.82 -49.9 10.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.007 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.79 -26.96 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.8 t -49.87 -40.29 42.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.346 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.61 8.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 1.9 m -85.98 127.71 34.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.162 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -98.32 35.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.251 -0.881 . . . . 1.0 110.915 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.339 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.544 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.6 p -80.53 -38.67 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.91 -31.34 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.55 -25.77 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 34.9 t -52.14 120.89 5.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.33 -26.08 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.32 125.61 43.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 -46.84 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.373 2.048 . . . . 0.0 112.353 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -87.53 55.41 3.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.84 30.31 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.98 65.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.981 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -161.07 29.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 57.41 28.07 14.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 1.6 p30 -111.76 150.57 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.115 0.483 . . . . 0.0 111.041 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.21 -44.05 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.272 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.97 -27.73 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 21' ' ' THR . . . -94.89 -24.01 17.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.16 -47.81 17.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.9 t -46.39 -26.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -50.17 -40.44 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 111.251 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.01 -36.69 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.8 m -86.78 -176.14 5.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.204 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -163.35 31.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.3 p -85.39 -28.96 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -60.03 -32.35 70.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.733 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -100.39 26.77 6.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.84 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.2 t -87.13 107.59 18.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.68 30.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.26 102.01 53.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.31 62.11 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.382 2.055 . . . . 0.0 112.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -178.71 36.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -116.19 -23.11 8.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.8 92.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.808 0.337 . . . . 0.0 111.358 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.71 -46.23 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.965 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -152.9 24.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.256 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.7 29.33 9.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.325 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.3 p30 -105.55 146.4 29.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.484 . . . . 0.0 111.14 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.24 -44.78 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.227 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.39 -27.52 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 21' ' ' THR . . . -95.83 -23.19 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.31 -49.77 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.896 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 t -46.03 -26.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.6 t -49.64 -40.43 39.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.23 -36.9 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.142 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.4 m -85.88 126.34 33.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.157 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.11 39.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.856 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.6 p 43.85 30.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.506 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.89 -45.38 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -84.96 -18.63 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.856 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 44.7 t -51.07 115.44 1.54 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -97.22 34.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -133.68 90.77 27.29 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.01 62.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -176.31 36.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HG ' ' CD2' ' A' ' 22' ' ' HIS . 7.1 m -98.66 -58.49 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -115.39 158.65 22.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.38 13.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.13 28.62 8.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.9 29.31 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.197 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.762 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 6.9 p30 -80.02 143.73 33.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -100.23 -43.04 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.305 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.77 -27.35 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.214 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.762 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -96.4 -21.85 17.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.224 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.88 -52.93 6.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 t -45.73 -27.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.9 t -49.66 -40.43 39.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.98 -36.15 8.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.286 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -85.92 135.63 33.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.221 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -111.04 31.58 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 1.0 110.886 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.687 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.536 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.3 p -106.05 -23.88 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.5 -29.13 61.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -106.91 24.07 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 8.1 t -86.67 112.53 21.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.524 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -75.9 -31.53 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 10' ' ' CYS . 1.9 tt -59.73 110.62 2.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.78 -57.45 2.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.493 2.129 . . . . 0.0 112.392 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 7' ' ' LEU . 5.7 mttm -124.42 95.65 4.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.637 ' HB3' HD13 ' A' ' 7' ' ' LEU . 28.6 p -115.51 -40.68 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 -167.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.8 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.086 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.55 30.35 3.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.54 58.31 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -79.89 147.1 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.195 0.521 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.687 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -100.29 -44.92 11.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.405 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.94 -12.36 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.572 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 21' ' ' THR . . . -122.08 13.54 10.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -90.21 -53.84 4.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.2 t -46.39 -26.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.3 t -49.89 -40.6 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.334 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.16 -35.5 8.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.157 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -86.83 179.45 6.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.173 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.57 35.71 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.187 -0.911 . . . . 1.0 110.993 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.559 ' O ' ' CE1' ' A' ' 19' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 16' ' ' VAL . 11.9 p -100.55 -27.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -32.19 62.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.49 -24.03 21.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.6 t -53.11 127.31 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.881 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.8 pt -84.8 -30.2 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 126.5 78.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.5 -45.08 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.46 2.107 . . . . 0.0 112.339 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -105.38 75.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.78 -33.92 6.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -139.54 152.22 46.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 25.43 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.39 34.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.79 27.89 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.349 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' ND2' ' HB1' ' A' ' 11' ' ' ALA . 7.3 p30 -80.05 132.6 36.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.4 t -100.14 -48.05 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.883 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.17 -28.22 4.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.24 -24.3 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.42 -49.81 11.78 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -46.24 -26.86 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.4 t -50.08 -40.07 44.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 0.0 111.342 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.66 8.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.121 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -86.15 133.29 33.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.156 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -114.03 31.41 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.931 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.554 ' O ' ' CE1' ' A' ' 19' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.878 0.37 . . . . 0.0 111.009 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.622 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.8 p -94.5 -38.92 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -32.67 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 -24.67 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.0 t -52.34 119.37 4.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -96.84 35.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.6 tt -133.19 94.45 20.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.87 53.67 4.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.602 2.202 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER 179.1 37.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.6 p -111.02 -41.1 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.795 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.1 -166.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.62 -43.89 1.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.11 28.07 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.43 35.76 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.231 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.658 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 19.5 p30 -79.82 153.3 29.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.469 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.622 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.27 -45.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -66.2 -24.36 66.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.247 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB3' ' CG ' ' A' ' 15' ' ' ASN . . . -101.9 -4.3 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.743 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -84.71 -53.13 5.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.744 0.306 . . . . 0.0 110.766 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.6 t -46.41 -26.56 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.638 0.256 . . . . 0.0 111.666 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.8 t -50.87 -40.21 55.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.449 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.74 -32.59 9.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.257 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.7 m -90.58 -178.53 5.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.185 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.05 35.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 mttp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.272 -0.871 . . . . 1.0 110.885 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.559 ' O ' ' CE1' ' A' ' 19' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -99.59 -29.61 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -55.9 -32.41 63.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.709 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -88.07 -24.84 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.787 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 40.7 t -53.87 114.54 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.8 pp -97.54 35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.418 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -101.16 140.36 21.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.418 ' HD2' HD23 ' A' ' 7' ' ' LEU . 56.1 Cg_endo -70.34 95.59 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 112.269 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 60.1 69.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -70.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.3 -29.27 9.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.05 14.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -146.24 20.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.265 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.61 26.79 4.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.379 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 3.2 p30 -107.35 130.94 54.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.213 0.53 . . . . 0.0 111.013 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.3 t -100.21 -47.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.889 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.44 -28.01 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 21' ' ' THR . . . -92.05 -24.31 19.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.8 -50.57 11.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.3 t -45.94 -27.02 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.0 t -49.62 -40.27 38.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 111.363 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.47 -36.68 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.186 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.7 m -85.93 132.57 34.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.18 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.53 32.42 4.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 mttp . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.891 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.657 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -105.67 -33.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -31.07 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.655 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -84.59 -25.46 28.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 33.0 t -53.44 133.58 40.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 pt -97.07 -36.09 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt -54.99 108.12 1.07 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.03 44.87 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.658 2.238 . . . . 0.0 112.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 176.76 39.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.645 ' HB3' HD13 ' A' ' 7' ' ' LEU . 18.2 p -99.97 -40.14 7.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.53 -168.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.75 -57.59 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.81 30.92 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.22 47.38 11.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 16.4 p30 -79.88 148.32 31.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.657 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.28 -44.96 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.289 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.86 -25.28 61.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.188 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG22 ' A' ' 21' ' ' THR . . . -101.89 3.63 39.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.726 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -87.82 -53.39 4.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 t -46.51 -26.65 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.634 0.254 . . . . 0.0 111.68 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.4 t -50.31 -40.52 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 111.361 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.69 -33.96 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.141 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -88.81 -177.7 5.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.199 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -145.33 31.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 1.0 110.929 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.798 0.332 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 2' ' ' VAL . 13.9 p 43.5 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.494 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.54 -45.23 3.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -94.64 14.92 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.081 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -63.81 -62.21 1.79 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt 42.3 30.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.831 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -98.79 138.26 20.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.17 90.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.404 2.069 . . . . 0.0 112.256 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 62.38 117.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -72.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -98.48 154.51 17.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.098 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.2 23.62 7.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' ASN . . . -170.26 32.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 51.24 26.75 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.394 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.534 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 8.7 p30 -80.02 140.29 36.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.128 0.489 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 20' ' ' THR . 0.8 OUTLIER -100.36 -44.39 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.366 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.25 -27.11 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.349 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.79 -20.76 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.0 -54.53 4.99 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 16' ' ' VAL . 6.4 t -45.6 -27.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.5 t -49.86 -40.08 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.88 0.371 . . . . 0.0 111.369 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.95 -35.48 8.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.358 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.0 m -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.308 -179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -111.29 31.28 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mttp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.874 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.652 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.814 0.34 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.553 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -100.93 -24.07 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -30.77 63.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -100.56 26.69 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 21.1 t -89.53 113.73 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.656 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.59 35.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 10' ' ' CYS . 3.7 tt -138.88 91.75 11.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.771 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.77 54.78 4.13 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.535 2.157 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 tttt 174.22 39.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.861 ' HB3' HD22 ' A' ' 7' ' ' LEU . 17.8 p -107.02 -40.58 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.66 -175.67 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.1 -38.28 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.5 29.2 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.24 50.87 9.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -79.96 144.01 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.807 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.32 -44.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.437 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -72.77 -22.48 60.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.325 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.46 10.47 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.717 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -93.88 -56.23 2.95 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.903 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -45.84 -26.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.0 t -49.97 -40.5 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -104.64 -33.12 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.281 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -88.82 177.35 6.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.226 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -142.98 33.61 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 1.0 110.941 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 1.002 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.329 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.96 30.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.636 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -95.31 -41.73 8.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.56 25.45 6.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.754 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.4 t -80.66 97.9 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.97 35.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -108.47 119.73 48.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.762 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.42 -28.15 34.34 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -168.26 86.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.566 ' HB3' HD13 ' A' ' 7' ' ' LEU . 30.4 p -95.41 -40.93 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -122.64 -40.92 2.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.81 29.94 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.139 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -139.13 14.81 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.0 25.61 3.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.685 0.279 . . . . 0.0 111.475 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -85.16 135.54 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.917 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 1.002 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.42 -44.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.413 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.75 -25.22 61.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . . . -103.88 6.88 36.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.784 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -91.33 -54.87 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.6 t -46.19 -26.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.9 t -49.6 -40.61 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.345 . . . . 0.0 111.371 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -103.62 -35.48 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.213 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.5 m -86.24 178.2 7.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.173 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -156.83 32.3 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.253 -0.88 . . . . 1.0 110.942 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.566 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.7 p 44.25 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.594 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.64 -44.64 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -98.65 23.37 8.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 30.7 t -72.94 78.88 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 pt -60.46 -29.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.0 OUTLIER -57.03 109.42 1.71 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.2 -47.48 26.6 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.447 ' C ' HD22 ' A' ' 7' ' ' LEU . 10.1 tttt -133.18 97.32 3.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' HD22 ' A' ' 7' ' ' LEU . 28.7 p -113.79 -40.5 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' ' HE1' ' A' ' 22' ' ' HIS . . . -136.17 -46.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.98 47.04 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -136.92 13.13 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.83 24.68 3.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.511 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.2 p30 -106.15 142.24 36.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.869 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.34 -45.38 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.397 -179.289 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -62.17 -25.23 67.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.182 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.65 -10.71 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.604 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.589 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -84.03 -55.98 3.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.979 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 t -45.94 -26.89 0.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -49.44 -40.41 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.407 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.651 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -104.09 -35.21 8.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.247 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.3 m -86.24 126.09 34.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.139 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -97.09 39.28 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.892 . . . . 1.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.909 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.0 p -94.12 -28.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -58.61 -30.38 67.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.909 ' CE1' ' HB3' ' A' ' 1' ' ' ALA . 1.7 p90 -125.76 23.07 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.19 93.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.369 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 7' ' ' LEU . 2.7 pp -57.3 -42.96 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.375 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.5 tt -53.47 107.81 0.95 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.488 2.125 . . . . 0.0 112.344 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 59.91 64.52 1.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.987 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.814 ' HB3' HD22 ' A' ' 7' ' ' LEU . 31.3 p -89.87 -30.54 17.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.818 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . . . -154.06 -45.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.26 66.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -138.92 14.32 2.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.395 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.31 23.33 4.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.618 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.67 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 2.0 p30 -117.39 140.76 49.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 110.99 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.44 -45.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -59.07 -28.38 66.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.51 -17.81 22.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.603 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.89 -50.64 10.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.813 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.5 t -46.96 -26.01 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.2 t -51.38 -39.68 57.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.37 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.13 -35.53 8.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.3 m -86.75 174.21 8.97 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.144 -179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.73 45.53 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.189 -0.91 . . . . 1.0 110.953 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.806 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.792 0.329 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.97 30.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.721 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.25 -59.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.09 -18.89 60.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.7 t -50.38 130.13 22.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.017 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 pt -138.76 29.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 8' ' ' PRO . 8.4 tt -83.67 137.61 41.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.637 ' N ' HD23 ' A' ' 7' ' ' LEU . 49.2 Cg_exo -55.65 85.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.437 2.091 . . . . 0.0 112.359 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 55.34 83.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.3 p -90.96 -40.48 11.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.25 -167.03 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.63 -46.36 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.32 31.54 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.26 53.59 5.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -79.81 145.17 32.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.3 -43.77 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.344 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.89 -18.25 60.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . . . -114.21 11.3 17.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.781 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -90.78 -55.64 3.49 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.81 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 t -46.32 -26.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.7 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.5 t -49.92 -40.6 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 0.0 111.303 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.72 -34.66 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.167 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.6 m -87.14 179.34 6.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.272 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.94 31.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.877 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.671 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.0 p 44.24 30.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.734 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.74 -44.32 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -98.72 26.59 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.73 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.0 t -73.78 66.82 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.82 -23.0 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.437 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.494 HD22 ' CA ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -54.56 138.5 60.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' HD23 ' A' ' 7' ' ' LEU . 74.5 Cg_endo -75.05 87.35 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mttp 59.14 65.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.494 ' CA ' HD22 ' A' ' 7' ' ' LEU . 30.2 p -60.74 -40.28 91.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 -47.18 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.34 71.85 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -154.6 25.86 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.53 23.88 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 8.8 p30 -99.55 125.46 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.671 HG21 ' HB1' ' A' ' 1' ' ' ALA . 1.4 t -100.29 -63.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.038 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -54.07 -26.59 27.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.594 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.58 -12.07 30.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.601 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.96 -55.23 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 0.0 110.865 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.8 t -45.65 -26.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.3 t -49.21 -40.52 33.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER -103.63 -35.6 8.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 111.221 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -85.99 128.6 34.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.185 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -98.71 31.57 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.209 -0.9 . . . . 1.0 110.883 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.815 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.0 p 44.01 30.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.7 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.586 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -75.76 -20.05 58.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.915 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.7 t -51.82 109.81 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.5 pt -97.72 30.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.053 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.3 tt -121.55 93.18 48.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 53.18 4.11 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.529 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tttm 177.39 38.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.63 ' HB3' HD22 ' A' ' 7' ' ' LEU . 20.6 p -106.84 -41.3 5.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.06 -168.11 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.06 -39.31 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.35 48.57 1.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.0 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -79.94 143.75 33.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.27 -43.87 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.346 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -73.83 -21.89 59.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.327 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 21' ' ' THR . . . -108.54 9.49 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.667 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -91.89 -56.42 3.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 110.814 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.8 t -46.12 -26.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.9 t -50.11 -40.4 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.43 -33.52 8.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.25 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.5 m -88.4 179.9 6.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.211 -179.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.71 31.79 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.19 -0.909 . . . . 1.0 110.89 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' A' ' 19' ' ' HIS . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.746 0.308 . . . . 0.0 111.067 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.609 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.8 p -79.47 -34.35 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.17 -31.5 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.666 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.28 22.17 11.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 17.2 t -85.38 110.22 18.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.596 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.14 34.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.18 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 10' ' ' CYS . 4.0 tt -133.95 82.42 49.15 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.73 57.09 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.901 2.401 . . . . 0.0 112.345 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.99 38.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.676 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -108.97 -40.32 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.88 -175.11 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.43 36.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -133.99 10.27 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.537 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.57 25.49 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.805 0.336 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 6.8 p30 -104.18 151.22 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.16 0.505 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.609 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.9 OUTLIER -100.27 -45.38 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.294 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -54.97 -24.46 24.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.13 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 21' ' ' THR . . . -100.68 -17.82 16.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.383 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.43 -53.44 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.807 0.337 . . . . 0.0 110.856 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.6 t -46.38 -26.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.7 t -51.23 -39.85 57.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 111.366 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.18 -33.45 8.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.5 m -89.0 139.1 30.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.153 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -95.37 44.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.943 179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -94.56 -24.17 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -55.25 -32.31 62.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -101.82 24.75 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 19.0 t -82.5 102.33 11.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 pt -76.41 -4.86 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.57 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.4 tt -106.06 92.79 6.94 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.3 53.64 4.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.585 2.19 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm 175.78 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.591 ' HB3' HD22 ' A' ' 7' ' ' LEU . 29.2 p -102.19 -40.8 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.52 -174.5 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.44 30.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.174 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.91 22.42 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.54 27.68 6.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.435 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 16.2 p30 -80.77 133.59 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.328 0.585 . . . . 0.0 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 1' ' ' ALA . 1.4 t -100.15 -63.74 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.979 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -55.81 -29.18 59.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 21' ' ' THR . . . -88.36 -9.9 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.442 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.612 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.83 -53.34 6.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.784 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 5.1 t -46.3 -26.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.5 t -50.88 -39.94 55.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.399 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.97 -33.63 8.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.233 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.0 m -88.79 177.77 6.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.57 37.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.278 -0.868 . . . . 1.0 110.868 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.977 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 2' ' ' VAL . 10.7 p 44.04 30.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.603 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -56.04 3.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.551 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -89.31 7.81 33.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.1 t -60.16 109.35 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 pt -97.09 31.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 10' ' ' CYS . 1.4 tt -141.01 87.42 10.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.702 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 -26.8 75.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.511 2.141 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -96.89 42.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.513 ' N ' HD22 ' A' ' 7' ' ' LEU . 15.4 p -106.67 -40.71 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.05 -166.52 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 -47.06 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.233 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.1 43.19 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.45 41.25 16.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.78 143.46 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.977 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.25 -43.81 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.439 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -74.47 59.0 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.018 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . 166.5 -31.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -49.99 -50.57 46.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.5 t -46.77 -26.13 0.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 18' ' ' ALA . 3.5 t -51.95 -38.96 58.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 0.0 111.489 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.91 -33.92 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.226 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -88.9 176.45 7.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.214 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.65 34.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.881 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.737 0.304 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.9 p -87.45 -27.61 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.02 -30.85 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -97.58 23.73 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.0 t -91.83 121.43 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.679 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.8 pt -96.76 35.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.441 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.646 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -120.72 132.86 24.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.763 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.646 ' HD2' HD23 ' A' ' 7' ' ' LEU . 60.7 Cg_endo -73.02 -45.6 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.49 2.127 . . . . 0.0 112.371 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.72 66.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -94.43 -68.28 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.949 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -99.03 141.67 31.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.194 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.21 -47.71 26.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.04 28.86 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.09 27.8 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.789 ' OD1' ' HB1' ' A' ' 11' ' ' ALA . 21.7 p-10 -80.98 145.23 31.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.33 -44.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.311 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.452 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.19 -27.13 5.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.0 -21.98 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.323 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.82 -49.9 10.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.007 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.79 -26.96 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.8 t -49.87 -40.29 42.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.346 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.61 8.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 1.9 m -85.98 127.71 34.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.162 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -98.32 35.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.251 -0.881 . . . . 1.0 110.915 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.339 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.544 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.6 p -80.53 -38.67 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.91 -31.34 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.55 -25.77 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 34.9 t -52.14 120.89 5.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.33 -26.08 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.32 125.61 43.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 -46.84 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.373 2.048 . . . . 0.0 112.353 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -87.53 55.41 3.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.84 30.31 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.98 65.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.981 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -161.07 29.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 57.41 28.07 14.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 1.6 p30 -111.76 150.57 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.115 0.483 . . . . 0.0 111.041 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.21 -44.05 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.272 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.97 -27.73 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 21' ' ' THR . . . -94.89 -24.01 17.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.16 -47.81 17.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.9 t -46.39 -26.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -50.17 -40.44 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 111.251 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.01 -36.69 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.523 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.8 m -86.78 -176.14 5.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -163.35 31.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.3 p -85.39 -28.96 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -60.03 -32.35 70.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.733 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -100.39 26.77 6.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.84 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.2 t -87.13 107.59 18.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.68 30.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.26 102.01 53.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.31 62.11 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.382 2.055 . . . . 0.0 112.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -178.71 36.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 17.3 m -116.19 -23.11 8.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.8 92.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.808 0.337 . . . . 0.0 111.358 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.71 -46.23 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.965 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -152.9 24.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.256 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.7 29.33 9.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.325 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.3 p30 -105.55 146.4 29.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.484 . . . . 0.0 111.14 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.24 -44.78 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.227 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.39 -27.52 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 21' ' ' THR . . . -95.83 -23.19 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.31 -49.77 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.896 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.486 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.2 t -46.03 -26.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.6 t -49.64 -40.43 39.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.23 -36.9 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.142 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.4 m -85.88 126.34 33.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.157 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.11 39.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.856 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.6 p 43.85 30.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.506 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.89 -45.38 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -84.96 -18.63 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.856 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.7 t -51.07 115.44 1.54 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -97.22 34.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -133.68 90.77 27.29 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.01 62.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -176.31 36.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -98.66 -58.49 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -115.39 158.65 22.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.38 13.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.13 28.62 8.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.9 29.31 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.197 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.762 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 6.9 p30 -80.02 143.73 33.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -100.23 -43.04 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.305 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.77 -27.35 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.214 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.762 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -96.4 -21.85 17.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.224 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.88 -52.93 6.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.489 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.1 t -45.73 -27.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.9 t -49.66 -40.43 39.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.98 -36.15 8.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.286 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -85.92 135.63 33.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.221 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -111.04 31.58 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 1.0 110.886 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.687 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.536 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.3 p -106.05 -23.88 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.5 -29.13 61.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -106.91 24.07 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.402 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 8.1 t -86.67 112.53 21.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -75.9 -31.53 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 10' ' ' CYS . 1.9 tt -59.73 110.62 2.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.78 -57.45 2.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.493 2.129 . . . . 0.0 112.392 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 7' ' ' LEU . 5.7 mttm -124.42 95.65 4.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.637 ' HB3' HD13 ' A' ' 7' ' ' LEU . 28.6 p -115.51 -40.68 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 -167.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.8 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.086 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.55 30.35 3.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.54 58.31 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -79.89 147.1 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.195 0.521 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.687 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -100.29 -44.92 11.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.405 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.94 -12.36 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.572 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 21' ' ' THR . . . -122.08 13.54 10.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -90.21 -53.84 4.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.2 t -46.39 -26.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.3 t -49.89 -40.6 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.334 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.16 -35.5 8.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.157 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.83 179.45 6.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.57 35.71 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.187 -0.911 . . . . 1.0 110.993 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 16' ' ' VAL . 11.9 p -100.55 -27.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -32.19 62.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.49 -24.03 21.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.6 t -53.11 127.31 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.881 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.8 pt -84.8 -30.2 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 126.5 78.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.5 -45.08 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.46 2.107 . . . . 0.0 112.339 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -105.38 75.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.406 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -108.78 -33.92 6.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -139.54 152.22 46.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 25.43 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.39 34.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.79 27.89 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.349 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' ND2' ' HB1' ' A' ' 11' ' ' ALA . 7.3 p30 -80.05 132.6 36.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.4 t -100.14 -48.05 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.883 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.17 -28.22 4.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.24 -24.3 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.42 -49.81 11.78 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.24 -26.86 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.4 t -50.08 -40.07 44.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 0.0 111.342 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.66 8.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.121 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.15 133.29 33.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.156 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -114.03 31.41 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.931 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.878 0.37 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.622 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.8 p -94.5 -38.92 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -32.67 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 -24.67 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.0 t -52.34 119.37 4.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -96.84 35.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.6 tt -133.19 94.45 20.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.87 53.67 4.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.602 2.202 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER 179.1 37.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.6 p -111.02 -41.1 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.795 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.1 -166.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.62 -43.89 1.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.11 28.07 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.43 35.76 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.231 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.658 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 19.5 p30 -79.82 153.3 29.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.469 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.622 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.27 -45.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -66.2 -24.36 66.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.247 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB3' ' CG ' ' A' ' 15' ' ' ASN . . . -101.9 -4.3 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.743 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -84.71 -53.13 5.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.744 0.306 . . . . 0.0 110.766 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 1.6 t -46.41 -26.56 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.638 0.256 . . . . 0.0 111.666 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.8 t -50.87 -40.21 55.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.449 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.74 -32.59 9.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.257 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.7 m -90.58 -178.53 5.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.185 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.05 35.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 mttp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.272 -0.871 . . . . 1.0 110.885 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -99.59 -29.61 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -55.9 -32.41 63.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.709 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -88.07 -24.84 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.787 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 40.7 t -53.87 114.54 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.8 pp -97.54 35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.418 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -101.16 140.36 21.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.418 ' HD2' HD23 ' A' ' 7' ' ' LEU . 56.1 Cg_endo -70.34 95.59 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 112.269 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 60.1 69.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -59.41 -70.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.3 -29.27 9.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.05 14.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -146.24 20.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.265 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.61 26.79 4.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.379 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 3.2 p30 -107.35 130.94 54.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.213 0.53 . . . . 0.0 111.013 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.3 t -100.21 -47.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.889 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.44 -28.01 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 21' ' ' THR . . . -92.05 -24.31 19.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.8 -50.57 11.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.3 t -45.94 -27.02 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.0 t -49.62 -40.27 38.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 111.363 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.47 -36.68 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.186 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.7 m -85.93 132.57 34.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.18 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.53 32.42 4.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 mttp . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.891 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.657 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -105.67 -33.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -31.07 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.655 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -84.59 -25.46 28.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 33.0 t -53.44 133.58 40.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 pt -97.07 -36.09 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt -54.99 108.12 1.07 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.03 44.87 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.658 2.238 . . . . 0.0 112.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 176.76 39.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.645 ' HB3' HD13 ' A' ' 7' ' ' LEU . 18.2 p -99.97 -40.14 7.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.53 -168.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.75 -57.59 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.81 30.92 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.22 47.38 11.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 16.4 p30 -79.88 148.32 31.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.657 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.28 -44.96 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.289 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.86 -25.28 61.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.188 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG22 ' A' ' 21' ' ' THR . . . -101.89 3.63 39.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.726 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -87.82 -53.39 4.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.6 t -46.51 -26.65 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.634 0.254 . . . . 0.0 111.68 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.4 t -50.31 -40.52 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 111.361 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.69 -33.96 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.141 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.81 -177.7 5.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.199 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -145.33 31.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 1.0 110.929 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.798 0.332 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 2' ' ' VAL . 13.9 p 43.5 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.494 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.54 -45.23 3.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -94.64 14.92 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.081 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 42.0 t -63.81 -62.21 1.79 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt 42.3 30.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.831 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -98.79 138.26 20.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.17 90.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.404 2.069 . . . . 0.0 112.256 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 62.38 117.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -72.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -98.48 154.51 17.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.098 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.2 23.62 7.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' ASN . . . -170.26 32.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 51.24 26.75 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.394 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.534 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 8.7 p30 -80.02 140.29 36.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.128 0.489 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 20' ' ' THR . 0.8 OUTLIER -100.36 -44.39 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.366 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.25 -27.11 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.349 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.79 -20.76 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.0 -54.53 4.99 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 16' ' ' VAL . 6.4 t -45.6 -27.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.5 t -49.86 -40.08 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.88 0.371 . . . . 0.0 111.369 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.95 -35.48 8.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.358 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.0 m -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -111.29 31.28 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mttp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.874 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.652 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.814 0.34 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.553 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -100.93 -24.07 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -30.77 63.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -100.56 26.69 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 21.1 t -89.53 113.73 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.656 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.59 35.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 10' ' ' CYS . 3.7 tt -138.88 91.75 11.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.771 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.77 54.78 4.13 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.535 2.157 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 tttt 174.22 39.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.861 ' HB3' HD22 ' A' ' 7' ' ' LEU . 17.8 p -107.02 -40.58 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.66 -175.67 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.1 -38.28 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.5 29.2 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.24 50.87 9.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -79.96 144.01 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.807 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.32 -44.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.437 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -72.77 -22.48 60.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.325 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.46 10.47 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.717 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -93.88 -56.23 2.95 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.903 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.9 t -45.84 -26.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.0 t -49.97 -40.5 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -104.64 -33.12 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.281 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.545 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.82 177.35 6.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.226 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -142.98 33.61 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 1.0 110.941 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.002 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.329 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.96 30.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.636 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -95.31 -41.73 8.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.56 25.45 6.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.754 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.4 t -80.66 97.9 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.97 35.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -108.47 119.73 48.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.762 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.42 -28.15 34.34 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -168.26 86.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.566 ' HB3' HD13 ' A' ' 7' ' ' LEU . 30.4 p -95.41 -40.93 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -122.64 -40.92 2.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.81 29.94 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.139 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -139.13 14.81 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.0 25.61 3.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.685 0.279 . . . . 0.0 111.475 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -85.16 135.54 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.917 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 1.002 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.42 -44.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.413 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.75 -25.22 61.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . . . -103.88 6.88 36.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.784 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -91.33 -54.87 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.478 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.19 -26.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.9 t -49.6 -40.61 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.345 . . . . 0.0 111.371 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -103.62 -35.48 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.213 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -86.24 178.2 7.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.173 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -156.83 32.3 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.253 -0.88 . . . . 1.0 110.942 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.566 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.7 p 44.25 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.594 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.64 -44.64 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -98.65 23.37 8.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.432 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 30.7 t -72.94 78.88 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 pt -60.46 -29.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.0 OUTLIER -57.03 109.42 1.71 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.2 -47.48 26.6 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.447 ' C ' HD22 ' A' ' 7' ' ' LEU . 10.1 tttt -133.18 97.32 3.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' HD22 ' A' ' 7' ' ' LEU . 28.7 p -113.79 -40.5 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' ' HE1' ' A' ' 22' ' ' HIS . . . -136.17 -46.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.98 47.04 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -136.92 13.13 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.83 24.68 3.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.511 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.2 p30 -106.15 142.24 36.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.869 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.34 -45.38 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.397 -179.289 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -62.17 -25.23 67.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.182 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.65 -10.71 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.604 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.589 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -84.03 -55.98 3.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.979 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.488 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.94 -26.89 0.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -49.44 -40.41 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.407 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.651 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -104.09 -35.21 8.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.247 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.24 126.09 34.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.139 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -97.09 39.28 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.892 . . . . 1.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.909 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.0 p -94.12 -28.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -58.61 -30.38 67.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.909 ' CE1' ' HB3' ' A' ' 1' ' ' ALA . 1.7 p90 -125.76 23.07 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.19 93.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.369 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 7' ' ' LEU . 2.7 pp -57.3 -42.96 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.375 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.5 tt -53.47 107.81 0.95 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.488 2.125 . . . . 0.0 112.344 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 59.91 64.52 1.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.987 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.814 ' HB3' HD22 ' A' ' 7' ' ' LEU . 31.3 p -89.87 -30.54 17.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.818 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . . . -154.06 -45.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.26 66.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -138.92 14.32 2.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.395 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.31 23.33 4.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.618 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.67 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 2.0 p30 -117.39 140.76 49.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 110.99 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.44 -45.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -59.07 -28.38 66.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.51 -17.81 22.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.603 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.89 -50.64 10.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.813 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.5 t -46.96 -26.01 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.2 t -51.38 -39.68 57.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.37 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.13 -35.53 8.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.75 174.21 8.97 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.144 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.73 45.53 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.189 -0.91 . . . . 1.0 110.953 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.806 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.792 0.329 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.97 30.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.721 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.25 -59.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.09 -18.89 60.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.7 t -50.38 130.13 22.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.017 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 pt -138.76 29.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 8' ' ' PRO . 8.4 tt -83.67 137.61 41.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' N ' HD23 ' A' ' 7' ' ' LEU . 49.2 Cg_exo -55.65 85.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.437 2.091 . . . . 0.0 112.359 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 55.34 83.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.3 p -90.96 -40.48 11.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.25 -167.03 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.63 -46.36 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.32 31.54 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.26 53.59 5.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -79.81 145.17 32.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.3 -43.77 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.344 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.89 -18.25 60.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . . . -114.21 11.3 17.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.781 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -90.78 -55.64 3.49 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.81 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.479 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 3.5 t -46.32 -26.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.7 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.5 t -49.92 -40.6 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 0.0 111.303 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.72 -34.66 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.167 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -87.14 179.34 6.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.272 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.94 31.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.877 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.671 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 2' ' ' VAL . 11.0 p 44.24 30.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.734 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.74 -44.32 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -98.72 26.59 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.73 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 45.0 t -73.78 66.82 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.82 -23.0 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.437 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.494 HD22 ' CA ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -54.56 138.5 60.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' HD23 ' A' ' 7' ' ' LEU . 74.5 Cg_endo -75.05 87.35 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mttp 59.14 65.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' CA ' HD22 ' A' ' 7' ' ' LEU . 30.2 p -60.74 -40.28 91.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 -47.18 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.34 71.85 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -154.6 25.86 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.53 23.88 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 8.8 p30 -99.55 125.46 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.671 HG21 ' HB1' ' A' ' 1' ' ' ALA . 1.4 t -100.29 -63.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.038 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -54.07 -26.59 27.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.594 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.58 -12.07 30.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.601 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.96 -55.23 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 0.0 110.865 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.8 t -45.65 -26.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.3 t -49.21 -40.52 33.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER -103.63 -35.6 8.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 111.221 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.9 m -85.99 128.6 34.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.185 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -98.71 31.57 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.209 -0.9 . . . . 1.0 110.883 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.815 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.0 p 44.01 30.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.7 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.586 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -75.76 -20.05 58.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.915 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.7 t -51.82 109.81 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.5 pt -97.72 30.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.053 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.3 tt -121.55 93.18 48.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 53.18 4.11 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.529 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tttm 177.39 38.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.63 ' HB3' HD22 ' A' ' 7' ' ' LEU . 20.6 p -106.84 -41.3 5.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.06 -168.11 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.06 -39.31 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.35 48.57 1.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.0 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -79.94 143.75 33.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.27 -43.87 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.346 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -73.83 -21.89 59.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.327 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 21' ' ' THR . . . -108.54 9.49 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.667 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -91.89 -56.42 3.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 110.814 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.495 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.12 -26.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.9 t -50.11 -40.4 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.43 -33.52 8.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.25 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.538 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -88.4 179.9 6.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.211 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.71 31.79 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.19 -0.909 . . . . 1.0 110.89 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.746 0.308 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.609 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.8 p -79.47 -34.35 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.17 -31.5 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.666 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.28 22.17 11.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.2 t -85.38 110.22 18.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.596 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.14 34.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.18 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 10' ' ' CYS . 4.0 tt -133.95 82.42 49.15 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.73 57.09 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.901 2.401 . . . . 0.0 112.345 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.99 38.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.676 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -108.97 -40.32 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.88 -175.11 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.43 36.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -133.99 10.27 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.537 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.57 25.49 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.805 0.336 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 6.8 p30 -104.18 151.22 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.16 0.505 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.609 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.9 OUTLIER -100.27 -45.38 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.294 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -54.97 -24.46 24.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.13 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 21' ' ' THR . . . -100.68 -17.82 16.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.383 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.43 -53.44 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.807 0.337 . . . . 0.0 110.856 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.38 -26.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.7 t -51.23 -39.85 57.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 111.366 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.18 -33.45 8.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.5 m -89.0 139.1 30.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.153 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -95.37 44.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.943 179.978 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -94.56 -24.17 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -55.25 -32.31 62.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -101.82 24.75 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 19.0 t -82.5 102.33 11.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 pt -76.41 -4.86 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.57 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.4 tt -106.06 92.79 6.94 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.3 53.64 4.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.585 2.19 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm 175.78 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.591 ' HB3' HD22 ' A' ' 7' ' ' LEU . 29.2 p -102.19 -40.8 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.52 -174.5 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.44 30.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.174 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.91 22.42 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.54 27.68 6.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.435 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 16.2 p30 -80.77 133.59 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.328 0.585 . . . . 0.0 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 1' ' ' ALA . 1.4 t -100.15 -63.74 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.979 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -55.81 -29.18 59.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 21' ' ' THR . . . -88.36 -9.9 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.442 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.612 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.83 -53.34 6.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.784 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.494 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.1 t -46.3 -26.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.5 t -50.88 -39.94 55.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.399 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.97 -33.63 8.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.233 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.0 m -88.79 177.77 6.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.57 37.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.278 -0.868 . . . . 1.0 110.868 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.977 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 2' ' ' VAL . 10.7 p 44.04 30.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.603 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -56.04 3.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.551 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -89.31 7.81 33.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.1 t -60.16 109.35 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 pt -97.09 31.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 10' ' ' CYS . 1.4 tt -141.01 87.42 10.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.702 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 -26.8 75.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.511 2.141 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -96.89 42.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.513 ' N ' HD22 ' A' ' 7' ' ' LEU . 15.4 p -106.67 -40.71 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.05 -166.52 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 -47.06 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.233 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.1 43.19 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.45 41.25 16.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.78 143.46 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.977 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.25 -43.81 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.439 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -74.47 59.0 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.018 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . 166.5 -31.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -49.99 -50.57 46.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.47 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.5 t -46.77 -26.13 0.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 18' ' ' ALA . 3.5 t -51.95 -38.96 58.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 0.0 111.489 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.91 -33.92 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.226 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.2 m -88.9 176.45 7.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.214 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.65 34.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.881 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.737 0.304 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.9 p -87.45 -27.61 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.02 -30.85 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -97.58 23.73 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.0 t -91.83 121.43 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.679 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.8 pt -96.76 35.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.441 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.646 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -120.72 132.86 24.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.763 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.646 ' HD2' HD23 ' A' ' 7' ' ' LEU . 60.7 Cg_endo -73.02 -45.6 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.49 2.127 . . . . 0.0 112.371 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.72 66.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -94.43 -68.28 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.949 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -99.03 141.67 31.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.194 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.21 -47.71 26.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.04 28.86 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.09 27.8 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.789 ' OD1' ' HB1' ' A' ' 11' ' ' ALA . 21.7 p-10 -80.98 145.23 31.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.33 -44.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.311 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.452 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.19 -27.13 5.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.0 -21.98 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.323 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.82 -49.9 10.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.007 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.79 -26.96 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.8 t -49.87 -40.29 42.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.346 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.61 8.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 1.9 m -85.98 127.71 34.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.162 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -98.32 35.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.251 -0.881 . . . . 1.0 110.915 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.339 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.544 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.6 p -80.53 -38.67 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.91 -31.34 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.55 -25.77 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 34.9 t -52.14 120.89 5.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.33 -26.08 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.32 125.61 43.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 -46.84 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.373 2.048 . . . . 0.0 112.353 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -87.53 55.41 3.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.84 30.31 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.98 65.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.981 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -161.07 29.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 57.41 28.07 14.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 1.6 p30 -111.76 150.57 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.115 0.483 . . . . 0.0 111.041 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.21 -44.05 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.272 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.97 -27.73 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 21' ' ' THR . . . -94.89 -24.01 17.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.16 -47.81 17.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.9 t -46.39 -26.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -50.17 -40.44 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 111.251 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.01 -36.69 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.523 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.8 m -86.78 -176.14 5.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -163.35 31.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.3 p -85.39 -28.96 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -60.03 -32.35 70.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.733 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -100.39 26.77 6.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.84 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.2 t -87.13 107.59 18.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.68 30.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.26 102.01 53.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.31 62.11 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.382 2.055 . . . . 0.0 112.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -178.71 36.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.3 m -116.19 -23.11 8.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.8 92.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.808 0.337 . . . . 0.0 111.358 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.71 -46.23 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.965 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -152.9 24.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.256 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.7 29.33 9.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.325 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.3 p30 -105.55 146.4 29.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.484 . . . . 0.0 111.14 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.24 -44.78 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.227 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.39 -27.52 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 21' ' ' THR . . . -95.83 -23.19 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.31 -49.77 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.896 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.486 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.2 t -46.03 -26.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.6 t -49.64 -40.43 39.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.23 -36.9 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.142 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.4 m -85.88 126.34 33.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.157 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.11 39.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.856 179.96 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.6 p 43.85 30.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.506 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.89 -45.38 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -84.96 -18.63 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.856 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.7 t -51.07 115.44 1.54 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -97.22 34.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -133.68 90.77 27.29 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.01 62.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -176.31 36.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HG ' ' CD2' ' A' ' 22' ' ' HIS . 7.1 m -98.66 -58.49 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -115.39 158.65 22.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.38 13.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.13 28.62 8.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.9 29.31 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.197 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.762 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 6.9 p30 -80.02 143.73 33.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -100.23 -43.04 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.305 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.77 -27.35 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.214 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.762 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -96.4 -21.85 17.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.224 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.88 -52.93 6.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.489 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.1 t -45.73 -27.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.9 t -49.66 -40.43 39.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.98 -36.15 8.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.286 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -85.92 135.63 33.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.221 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -111.04 31.58 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 1.0 110.886 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.687 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.536 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.3 p -106.05 -23.88 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.5 -29.13 61.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -106.91 24.07 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.402 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 8.1 t -86.67 112.53 21.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -75.9 -31.53 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 10' ' ' CYS . 1.9 tt -59.73 110.62 2.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.78 -57.45 2.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.493 2.129 . . . . 0.0 112.392 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 7' ' ' LEU . 5.7 mttm -124.42 95.65 4.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.637 ' HB3' HD13 ' A' ' 7' ' ' LEU . 28.6 p -115.51 -40.68 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 -167.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.8 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.086 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.55 30.35 3.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.54 58.31 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -79.89 147.1 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.195 0.521 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.687 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -100.29 -44.92 11.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.405 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.94 -12.36 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.572 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 21' ' ' THR . . . -122.08 13.54 10.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -90.21 -53.84 4.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.2 t -46.39 -26.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.3 t -49.89 -40.6 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.334 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.16 -35.5 8.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.157 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.83 179.45 6.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.57 35.71 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.187 -0.911 . . . . 1.0 110.993 -179.953 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 16' ' ' VAL . 11.9 p -100.55 -27.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -32.19 62.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.49 -24.03 21.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.6 t -53.11 127.31 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.881 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.8 pt -84.8 -30.2 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 126.5 78.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.5 -45.08 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.46 2.107 . . . . 0.0 112.339 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -105.38 75.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -108.78 -33.92 6.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -139.54 152.22 46.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 25.43 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.39 34.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.79 27.89 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.349 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' ND2' ' HB1' ' A' ' 11' ' ' ALA . 7.3 p30 -80.05 132.6 36.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.4 t -100.14 -48.05 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.883 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.17 -28.22 4.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.24 -24.3 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.42 -49.81 11.78 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.24 -26.86 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.4 t -50.08 -40.07 44.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 0.0 111.342 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.66 8.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.121 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.15 133.29 33.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.156 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -114.03 31.41 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.931 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.878 0.37 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.622 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.8 p -94.5 -38.92 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -32.67 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 -24.67 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.0 t -52.34 119.37 4.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -96.84 35.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.6 tt -133.19 94.45 20.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.87 53.67 4.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.602 2.202 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER 179.1 37.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.6 p -111.02 -41.1 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.795 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.1 -166.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.62 -43.89 1.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.11 28.07 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.43 35.76 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.231 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.658 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 19.5 p30 -79.82 153.3 29.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.469 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.622 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.27 -45.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -66.2 -24.36 66.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.247 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB3' ' CG ' ' A' ' 15' ' ' ASN . . . -101.9 -4.3 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.743 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -84.71 -53.13 5.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.744 0.306 . . . . 0.0 110.766 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 1.6 t -46.41 -26.56 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.638 0.256 . . . . 0.0 111.666 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.8 t -50.87 -40.21 55.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.449 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.74 -32.59 9.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.257 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.7 m -90.58 -178.53 5.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.185 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.05 35.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 mttp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.272 -0.871 . . . . 1.0 110.885 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -99.59 -29.61 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -55.9 -32.41 63.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.709 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -88.07 -24.84 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.787 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 40.7 t -53.87 114.54 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.8 pp -97.54 35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.418 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -101.16 140.36 21.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.418 ' HD2' HD23 ' A' ' 7' ' ' LEU . 56.1 Cg_endo -70.34 95.59 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 112.269 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 60.1 69.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -70.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.3 -29.27 9.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.05 14.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -146.24 20.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.265 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.61 26.79 4.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.379 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 3.2 p30 -107.35 130.94 54.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.213 0.53 . . . . 0.0 111.013 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.3 t -100.21 -47.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.889 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.44 -28.01 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 21' ' ' THR . . . -92.05 -24.31 19.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.8 -50.57 11.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.3 t -45.94 -27.02 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.0 t -49.62 -40.27 38.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 111.363 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.47 -36.68 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.186 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.7 m -85.93 132.57 34.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.18 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.53 32.42 4.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 mttp . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.891 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.657 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -105.67 -33.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -31.07 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.655 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -84.59 -25.46 28.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 33.0 t -53.44 133.58 40.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 pt -97.07 -36.09 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt -54.99 108.12 1.07 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.03 44.87 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.658 2.238 . . . . 0.0 112.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 176.76 39.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.645 ' HB3' HD13 ' A' ' 7' ' ' LEU . 18.2 p -99.97 -40.14 7.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.53 -168.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.75 -57.59 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.81 30.92 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.22 47.38 11.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 16.4 p30 -79.88 148.32 31.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.657 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.28 -44.96 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.289 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.86 -25.28 61.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.188 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG22 ' A' ' 21' ' ' THR . . . -101.89 3.63 39.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.726 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -87.82 -53.39 4.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.6 t -46.51 -26.65 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.634 0.254 . . . . 0.0 111.68 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.4 t -50.31 -40.52 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 111.361 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.69 -33.96 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.141 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.81 -177.7 5.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.199 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -145.33 31.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 1.0 110.929 -179.951 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.798 0.332 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 2' ' ' VAL . 13.9 p 43.5 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.494 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.54 -45.23 3.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -94.64 14.92 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.081 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 42.0 t -63.81 -62.21 1.79 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt 42.3 30.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.831 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -98.79 138.26 20.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.17 90.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.404 2.069 . . . . 0.0 112.256 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 62.38 117.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -72.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -98.48 154.51 17.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.098 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.2 23.62 7.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' ASN . . . -170.26 32.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 51.24 26.75 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.394 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.534 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 8.7 p30 -80.02 140.29 36.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.128 0.489 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 20' ' ' THR . 0.8 OUTLIER -100.36 -44.39 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.366 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.455 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.25 -27.11 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.349 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.79 -20.76 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.0 -54.53 4.99 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 16' ' ' VAL . 6.4 t -45.6 -27.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.5 t -49.86 -40.08 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.88 0.371 . . . . 0.0 111.369 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.95 -35.48 8.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.358 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.0 m -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -111.29 31.28 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mttp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.874 -179.986 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.652 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.814 0.34 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.553 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -100.93 -24.07 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -30.77 63.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -100.56 26.69 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 21.1 t -89.53 113.73 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.656 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.59 35.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 10' ' ' CYS . 3.7 tt -138.88 91.75 11.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.771 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.77 54.78 4.13 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.535 2.157 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 tttt 174.22 39.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.861 ' HB3' HD22 ' A' ' 7' ' ' LEU . 17.8 p -107.02 -40.58 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.66 -175.67 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.1 -38.28 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.5 29.2 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.24 50.87 9.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -79.96 144.01 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.807 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.32 -44.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.437 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -72.77 -22.48 60.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.325 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.46 10.47 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.717 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -93.88 -56.23 2.95 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.903 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.9 t -45.84 -26.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.0 t -49.97 -40.5 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -104.64 -33.12 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.281 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.545 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.82 177.35 6.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.226 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -142.98 33.61 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 1.0 110.941 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 1.002 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.329 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.96 30.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.636 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -95.31 -41.73 8.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.56 25.45 6.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.754 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.4 t -80.66 97.9 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.97 35.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -108.47 119.73 48.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.762 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.42 -28.15 34.34 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -168.26 86.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.566 ' HB3' HD13 ' A' ' 7' ' ' LEU . 30.4 p -95.41 -40.93 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -122.64 -40.92 2.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.81 29.94 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.139 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -139.13 14.81 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.0 25.61 3.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.685 0.279 . . . . 0.0 111.475 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -85.16 135.54 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.917 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 1.002 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.42 -44.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.413 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.75 -25.22 61.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . . . -103.88 6.88 36.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.784 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -91.33 -54.87 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.478 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.19 -26.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.9 t -49.6 -40.61 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.345 . . . . 0.0 111.371 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -103.62 -35.48 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.213 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -86.24 178.2 7.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.173 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -156.83 32.3 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.253 -0.88 . . . . 1.0 110.942 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.566 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.7 p 44.25 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.594 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.64 -44.64 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -98.65 23.37 8.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.432 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 30.7 t -72.94 78.88 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 pt -60.46 -29.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.0 OUTLIER -57.03 109.42 1.71 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.2 -47.48 26.6 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.447 ' C ' HD22 ' A' ' 7' ' ' LEU . 10.1 tttt -133.18 97.32 3.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' HD22 ' A' ' 7' ' ' LEU . 28.7 p -113.79 -40.5 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' ' HE1' ' A' ' 22' ' ' HIS . . . -136.17 -46.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.98 47.04 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -136.92 13.13 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.83 24.68 3.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.511 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.2 p30 -106.15 142.24 36.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.869 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.566 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.34 -45.38 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.397 -179.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.458 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -62.17 -25.23 67.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.182 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.65 -10.71 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.604 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.589 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -84.03 -55.98 3.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.979 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.488 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.94 -26.89 0.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -49.44 -40.41 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.407 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.651 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -104.09 -35.21 8.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.247 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.24 126.09 34.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.139 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -97.09 39.28 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.892 . . . . 1.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.909 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.0 p -94.12 -28.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -58.61 -30.38 67.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.909 ' CE1' ' HB3' ' A' ' 1' ' ' ALA . 1.7 p90 -125.76 23.07 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.19 93.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.369 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 7' ' ' LEU . 2.7 pp -57.3 -42.96 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.375 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.814 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.5 tt -53.47 107.81 0.95 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.488 2.125 . . . . 0.0 112.344 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 59.91 64.52 1.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.987 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.814 ' HB3' HD22 ' A' ' 7' ' ' LEU . 31.3 p -89.87 -30.54 17.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.818 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . . . -154.06 -45.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.26 66.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -138.92 14.32 2.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.395 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.31 23.33 4.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.618 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.67 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 2.0 p30 -117.39 140.76 49.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 110.99 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.44 -45.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -59.07 -28.38 66.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.51 -17.81 22.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.603 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.89 -50.64 10.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.813 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.5 t -46.96 -26.01 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.2 t -51.38 -39.68 57.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.37 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.13 -35.53 8.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.75 174.21 8.97 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.144 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.73 45.53 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.189 -0.91 . . . . 1.0 110.953 179.947 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.806 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.792 0.329 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.97 30.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.721 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.25 -59.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.09 -18.89 60.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.7 t -50.38 130.13 22.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.017 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 pt -138.76 29.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 8' ' ' PRO . 8.4 tt -83.67 137.61 41.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.637 ' N ' HD23 ' A' ' 7' ' ' LEU . 49.2 Cg_exo -55.65 85.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.437 2.091 . . . . 0.0 112.359 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 55.34 83.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.3 p -90.96 -40.48 11.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.25 -167.03 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.63 -46.36 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.32 31.54 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.26 53.59 5.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -79.81 145.17 32.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.3 -43.77 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.344 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.89 -18.25 60.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . . . -114.21 11.3 17.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.781 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -90.78 -55.64 3.49 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.81 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.479 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 3.5 t -46.32 -26.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.7 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.5 t -49.92 -40.6 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 0.0 111.303 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.72 -34.66 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.167 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -87.14 179.34 6.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.272 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.94 31.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.877 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.671 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.0 p 44.24 30.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.734 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.74 -44.32 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -98.72 26.59 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.73 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 45.0 t -73.78 66.82 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.82 -23.0 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.437 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.494 HD22 ' CA ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -54.56 138.5 60.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' HD23 ' A' ' 7' ' ' LEU . 74.5 Cg_endo -75.05 87.35 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mttp 59.14 65.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.494 ' CA ' HD22 ' A' ' 7' ' ' LEU . 30.2 p -60.74 -40.28 91.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 -47.18 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.34 71.85 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -154.6 25.86 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.53 23.88 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 8.8 p30 -99.55 125.46 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.671 HG21 ' HB1' ' A' ' 1' ' ' ALA . 1.4 t -100.29 -63.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.038 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -54.07 -26.59 27.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.594 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.58 -12.07 30.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.601 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.96 -55.23 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 0.0 110.865 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.8 t -45.65 -26.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.3 t -49.21 -40.52 33.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER -103.63 -35.6 8.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 111.221 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.9 m -85.99 128.6 34.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.185 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -98.71 31.57 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.209 -0.9 . . . . 1.0 110.883 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.815 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.0 p 44.01 30.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.7 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.586 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -75.76 -20.05 58.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.915 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.7 t -51.82 109.81 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.5 pt -97.72 30.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.053 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.3 tt -121.55 93.18 48.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 53.18 4.11 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.529 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tttm 177.39 38.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.63 ' HB3' HD22 ' A' ' 7' ' ' LEU . 20.6 p -106.84 -41.3 5.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.06 -168.11 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.06 -39.31 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.35 48.57 1.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.0 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -79.94 143.75 33.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.27 -43.87 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.346 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -73.83 -21.89 59.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.327 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 21' ' ' THR . . . -108.54 9.49 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.667 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -91.89 -56.42 3.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 110.814 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.495 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.12 -26.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.9 t -50.11 -40.4 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.43 -33.52 8.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.25 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.538 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -88.4 179.9 6.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.211 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.71 31.79 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.19 -0.909 . . . . 1.0 110.89 -179.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.746 0.308 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.609 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.8 p -79.47 -34.35 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.17 -31.5 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.666 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.28 22.17 11.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.2 t -85.38 110.22 18.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.596 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.14 34.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.18 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 10' ' ' CYS . 4.0 tt -133.95 82.42 49.15 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.73 57.09 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.901 2.401 . . . . 0.0 112.345 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.99 38.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.676 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -108.97 -40.32 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.88 -175.11 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.43 36.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -133.99 10.27 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.537 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.57 25.49 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.805 0.336 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 6.8 p30 -104.18 151.22 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.16 0.505 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.609 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.9 OUTLIER -100.27 -45.38 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.294 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -54.97 -24.46 24.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.13 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 21' ' ' THR . . . -100.68 -17.82 16.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.383 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.43 -53.44 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.807 0.337 . . . . 0.0 110.856 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.38 -26.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.7 t -51.23 -39.85 57.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 111.366 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.18 -33.45 8.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.5 m -89.0 139.1 30.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.153 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -95.37 44.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.943 179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -94.56 -24.17 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -55.25 -32.31 62.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -101.82 24.75 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 19.0 t -82.5 102.33 11.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 pt -76.41 -4.86 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.57 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.4 tt -106.06 92.79 6.94 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.3 53.64 4.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.585 2.19 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm 175.78 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.591 ' HB3' HD22 ' A' ' 7' ' ' LEU . 29.2 p -102.19 -40.8 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.52 -174.5 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.44 30.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.174 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.91 22.42 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.54 27.68 6.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.435 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 16.2 p30 -80.77 133.59 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.328 0.585 . . . . 0.0 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 1' ' ' ALA . 1.4 t -100.15 -63.74 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.979 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -55.81 -29.18 59.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 21' ' ' THR . . . -88.36 -9.9 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.442 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.612 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.83 -53.34 6.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.784 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.494 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.1 t -46.3 -26.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.5 t -50.88 -39.94 55.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.399 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.97 -33.63 8.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.233 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.0 m -88.79 177.77 6.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.57 37.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.278 -0.868 . . . . 1.0 110.868 179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.977 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 2' ' ' VAL . 10.7 p 44.04 30.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.603 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -56.04 3.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.551 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -89.31 7.81 33.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.1 t -60.16 109.35 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 pt -97.09 31.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 10' ' ' CYS . 1.4 tt -141.01 87.42 10.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.702 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 -26.8 75.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.511 2.141 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.438 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -96.89 42.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.513 ' N ' HD22 ' A' ' 7' ' ' LEU . 15.4 p -106.67 -40.71 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.05 -166.52 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 -47.06 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.233 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.1 43.19 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.45 41.25 16.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.78 143.46 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.977 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.25 -43.81 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.439 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -74.47 59.0 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.018 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . 166.5 -31.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -49.99 -50.57 46.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.47 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.5 t -46.77 -26.13 0.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 18' ' ' ALA . 3.5 t -51.95 -38.96 58.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 0.0 111.489 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.91 -33.92 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.226 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.2 m -88.9 176.45 7.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.214 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.65 34.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.881 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.41 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.737 0.304 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 16' ' ' VAL . 9.9 p -87.45 -27.61 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.983 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -58.02 -30.85 66.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.773 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -97.58 23.73 7.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.946 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.0 t -91.83 121.43 33.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.679 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.8 pt -96.76 35.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.441 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.646 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -120.72 132.86 24.05 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.763 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.646 ' HD2' HD23 ' A' ' 7' ' ' LEU . 60.7 Cg_endo -73.02 -45.6 0.45 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.49 2.127 . . . . 0.0 112.371 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 mttt -115.72 66.46 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -94.43 -68.28 0.81 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.949 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.789 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -99.03 141.67 31.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.194 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.21 -47.71 26.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.003 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.04 28.86 7.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.114 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.09 27.8 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.789 ' OD1' ' HB1' ' A' ' 11' ' ' ALA . 21.7 p-10 -80.98 145.23 31.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.175 0.512 . . . . 0.0 110.992 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.475 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.33 -44.66 11.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.311 -179.331 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.452 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.19 -27.13 5.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.227 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.0 -21.98 15.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.323 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.82 -49.9 10.5 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 111.007 -179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.79 -26.96 0.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.8 t -49.87 -40.29 42.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.924 0.392 . . . . 0.0 111.346 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.61 8.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.305 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.517 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 1.9 m -85.98 127.71 34.69 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.162 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -98.32 35.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.6 mtpt . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.251 -0.881 . . . . 1.0 110.915 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.811 0.339 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.544 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.6 p -80.53 -38.67 17.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.843 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -72.91 -31.34 64.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.63 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -80.55 -25.77 38.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.896 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 34.9 t -52.14 120.89 5.92 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.913 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -84.33 -26.08 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.395 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.32 125.61 43.49 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.989 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.84 -46.84 0.69 Allowed 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.373 2.048 . . . . 0.0 112.353 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -87.53 55.41 3.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.84 30.31 5.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.909 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.98 65.21 0.66 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.12 -39.49 82.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.981 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -161.07 29.39 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 57.41 28.07 14.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.259 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 1.6 p30 -111.76 150.57 30.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.115 0.483 . . . . 0.0 111.041 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.544 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.21 -44.05 11.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.272 -179.494 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.97 -27.73 5.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.16 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.599 ' O ' HG22 ' A' ' 21' ' ' THR . . . -94.89 -24.01 17.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.177 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.16 -47.81 17.31 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.797 -179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.476 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.9 t -46.39 -26.6 0.87 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.599 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -50.17 -40.44 46.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 111.251 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.616 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.01 -36.69 8.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.07 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.523 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.8 m -86.78 -176.14 5.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.204 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -163.35 31.45 0.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.871 179.959 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.806 0.336 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.3 p -85.39 -28.96 6.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.008 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -60.03 -32.35 70.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.733 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -100.39 26.77 6.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.84 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.417 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.2 t -87.13 107.59 18.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.629 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.2 pt -98.68 30.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.059 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.26 102.01 53.2 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.86 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.31 62.11 1.51 Allowed 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.382 2.055 . . . . 0.0 112.435 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -178.71 36.27 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.402 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 17.3 m -116.19 -23.11 8.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.186 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.8 92.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.808 0.337 . . . . 0.0 111.358 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -124.71 -46.23 1.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.965 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.434 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -152.9 24.21 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.256 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.7 29.33 9.29 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.325 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.434 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.3 p30 -105.55 146.4 29.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.115 0.484 . . . . 0.0 111.14 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 2' ' ' VAL . 1.0 OUTLIER -100.24 -44.78 11.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.227 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.39 -27.52 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.096 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' O ' HG22 ' A' ' 21' ' ' THR . . . -95.83 -23.19 17.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.133 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -80.31 -49.77 11.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.896 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.486 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.2 t -46.03 -26.93 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.6 t -49.64 -40.43 39.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.887 0.375 . . . . 0.0 111.325 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.23 -36.9 8.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.142 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.522 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.4 m -85.88 126.34 33.99 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.157 -179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -97.11 39.65 1.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.982 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 tttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.265 -0.874 . . . . 1.0 110.856 179.96 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.6 p 43.85 30.75 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.506 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -122.89 -45.38 2.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.508 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -84.96 -18.63 33.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.856 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.47 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 44.7 t -51.07 115.44 1.54 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.027 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.482 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.6 pp -97.22 34.91 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.151 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.4 tt -133.68 90.77 27.29 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.868 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.01 62.65 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.529 2.153 . . . . 0.0 112.317 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -176.31 36.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.1 m -98.66 -58.49 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -115.39 158.65 22.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.17 -33.38 13.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.108 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -108.13 28.62 8.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.104 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.9 29.31 18.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.197 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.762 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 6.9 p30 -80.02 143.73 33.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.1 0.476 . . . . 0.0 110.931 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.499 HG23 ' HB ' ' A' ' 2' ' ' VAL . 0.5 OUTLIER -100.23 -43.04 10.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.305 -179.399 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.441 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -49.77 -27.35 4.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.214 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.762 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -96.4 -21.85 17.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.224 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.88 -52.93 6.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.807 0.337 . . . . 0.0 110.964 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.489 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 10.1 t -45.73 -27.05 0.74 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.9 t -49.66 -40.43 39.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.916 0.389 . . . . 0.0 111.318 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.98 -36.15 8.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.286 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -85.92 135.63 33.6 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.221 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -111.04 31.58 5.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.904 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.7 mttp . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.211 -0.9 . . . . 1.0 110.886 -179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.687 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.536 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.3 p -106.05 -23.88 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.164 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -56.5 -29.13 61.47 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.859 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -106.91 24.07 13.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.402 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 8.1 t -86.67 112.53 21.72 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.524 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt -75.9 -31.53 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD13 ' HB3' ' A' ' 10' ' ' CYS . 1.9 tt -59.73 110.62 2.93 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -50.78 -57.45 2.26 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.493 2.129 . . . . 0.0 112.392 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.415 ' C ' HD22 ' A' ' 7' ' ' LEU . 5.7 mttm -124.42 95.65 4.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.637 ' HB3' HD13 ' A' ' 7' ' ' LEU . 28.6 p -115.51 -40.68 3.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 -167.94 1.32 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -99.8 -67.64 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.086 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.55 30.35 3.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.156 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.54 58.31 3.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.089 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -79.89 147.1 31.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.195 0.521 . . . . 0.0 110.879 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.687 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.7 OUTLIER -100.29 -44.92 11.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.405 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.94 -12.36 60.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.572 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 21' ' ' THR . . . -122.08 13.54 10.51 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -90.21 -53.84 4.29 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.81 0.338 . . . . 0.0 110.782 179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.2 t -46.39 -26.71 0.89 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.441 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.3 t -49.89 -40.6 43.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.902 0.382 . . . . 0.0 111.334 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.16 -35.5 8.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.157 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.83 179.45 6.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.173 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -110.57 35.71 3.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 tttp . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.187 -0.911 . . . . 1.0 110.993 -179.953 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.849 0.357 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.423 ' N ' HG22 ' A' ' 16' ' ' VAL . 11.9 p -100.55 -27.19 3.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.059 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -55.4 -32.19 62.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.69 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -89.49 -24.03 21.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.815 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.6 t -53.11 127.31 23.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.881 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.8 pt -84.8 -30.2 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.23 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.25 126.5 78.42 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.5 -45.08 0.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.46 2.107 . . . . 0.0 112.339 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -105.38 75.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.406 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -108.78 -33.92 6.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -139.54 152.22 46.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.088 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 25.43 10.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.172 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.39 34.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.181 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.79 27.89 5.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.349 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' ND2' ' HB1' ' A' ' 11' ' ' ALA . 7.3 p30 -80.05 132.6 36.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.246 0.546 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.423 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.4 t -100.14 -48.05 11.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.883 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.17 -28.22 4.23 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.156 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.602 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.24 -24.3 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.608 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.42 -49.81 11.78 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.856 0.36 . . . . 0.0 110.859 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.24 -26.86 0.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.4 t -50.08 -40.07 44.4 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.815 0.34 . . . . 0.0 111.342 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.608 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.43 -36.66 8.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.121 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.15 133.29 33.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.156 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -114.03 31.41 6.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.991 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.188 -0.91 . . . . 1.0 110.931 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 120.878 0.37 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.622 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.8 p -94.5 -38.92 9.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.7 -32.67 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.597 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.76 -24.67 22.59 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.842 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.431 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.0 t -52.34 119.37 4.36 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.944 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 pt -96.84 35.28 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.119 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.729 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.6 tt -133.19 94.45 20.23 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.841 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -78.87 53.67 4.78 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.602 2.202 . . . . 0.0 112.482 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' N ' HD23 ' A' ' 7' ' ' LEU . 0.0 OUTLIER 179.1 37.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.986 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.729 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.6 p -111.02 -41.1 4.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.795 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -100.1 -166.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -125.62 -43.89 1.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.176 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.11 28.07 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.263 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 56.43 35.76 26.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.231 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.658 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 19.5 p30 -79.82 153.3 29.21 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.469 . . . . 0.0 110.985 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.622 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.27 -45.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.331 -179.355 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -66.2 -24.36 66.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.247 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.658 ' HB3' ' CG ' ' A' ' 15' ' ' ASN . . . -101.9 -4.3 26.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.743 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.614 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -84.71 -53.13 5.57 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.744 0.306 . . . . 0.0 110.766 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 1.6 t -46.41 -26.56 0.86 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.638 0.256 . . . . 0.0 111.666 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.8 t -50.87 -40.21 55.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.449 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.614 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.74 -32.59 9.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.257 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.528 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.7 m -90.58 -178.53 5.33 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.185 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -155.05 35.16 0.39 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.9 mttp . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.272 -0.871 . . . . 1.0 110.885 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.794 0.33 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -99.59 -29.61 3.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.958 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -55.9 -32.41 63.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.709 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -88.07 -24.84 23.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.787 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.459 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 40.7 t -53.87 114.54 1.61 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.8 pp -97.54 35.03 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.418 HD23 ' HD2' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -101.16 140.36 21.22 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.418 ' HD2' HD23 ' A' ' 7' ' ' LEU . 56.1 Cg_endo -70.34 95.59 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.429 2.086 . . . . 0.0 112.269 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.4 mttp 60.1 69.55 0.69 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' ' NE2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -59.41 -70.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.96 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -106.3 -29.27 9.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.05 14.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.149 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.503 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -146.24 20.38 1.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.265 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.61 26.79 4.6 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.379 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.503 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 3.2 p30 -107.35 130.94 54.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.213 0.53 . . . . 0.0 111.013 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 2' ' ' VAL . 1.3 t -100.21 -47.55 11.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.889 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.44 -28.01 4.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.092 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.598 ' O ' HG22 ' A' ' 21' ' ' THR . . . -92.05 -24.31 19.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.098 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.607 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.8 -50.57 11.09 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.485 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.3 t -45.94 -27.02 0.8 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.0 t -49.62 -40.27 38.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.809 0.338 . . . . 0.0 111.363 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.607 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -102.47 -36.68 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.186 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.7 m -85.93 132.57 34.05 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.18 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -104.53 32.42 4.09 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 25.2 mttp . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.891 179.966 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.657 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -105.67 -33.36 2.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.925 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.95 -31.07 69.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.655 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 11.6 m-85 -84.59 -25.46 28.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.936 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 33.0 t -53.44 133.58 40.57 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.91 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.5 pt -97.07 -36.09 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.083 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 10' ' ' CYS . 2.0 tt -54.99 108.12 1.07 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.956 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -87.03 44.87 1.2 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.658 2.238 . . . . 0.0 112.731 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.4 tttt 176.76 39.55 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.645 ' HB3' HD13 ' A' ' 7' ' ' LEU . 18.2 p -99.97 -40.14 7.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.93 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.53 -168.51 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.153 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -114.75 -57.59 2.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.81 30.92 5.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.127 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.22 47.38 11.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.098 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 16.4 p30 -79.88 148.32 31.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.073 0.463 . . . . 0.0 110.981 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.657 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.7 OUTLIER -100.28 -44.96 11.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.289 -179.317 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.454 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.86 -25.28 61.89 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.188 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' HG22 ' A' ' 21' ' ' THR . . . -101.89 3.63 39.37 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.726 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -87.82 -53.39 4.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.846 0.355 . . . . 0.0 110.77 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.6 t -46.51 -26.65 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.634 0.254 . . . . 0.0 111.68 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.524 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.4 t -50.31 -40.52 48.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.885 0.374 . . . . 0.0 111.361 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.599 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.69 -33.96 8.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.141 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.533 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.81 -177.7 5.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.199 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -145.33 31.85 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.184 -0.912 . . . . 1.0 110.929 -179.951 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.447 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.798 0.332 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.631 ' O ' HG22 ' A' ' 2' ' ' VAL . 13.9 p 43.5 31.06 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.494 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -112.54 -45.23 3.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.646 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -94.64 14.92 19.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.081 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 42.0 t -63.81 -62.21 1.79 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.764 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.5 pt 42.3 30.62 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.831 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 5.4 tt -98.79 138.26 20.67 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.873 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.17 90.86 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.404 2.069 . . . . 0.0 112.256 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt 62.38 117.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -125.5 -72.98 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.488 ' HB1' ' ND2' ' A' ' 15' ' ' ASN . . . -98.48 154.51 17.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.098 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.2 23.62 7.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.247 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HD22 ' A' ' 15' ' ' ASN . . . -170.26 32.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.167 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 51.24 26.75 3.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.394 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.534 ' OD1' ' HB3' ' A' ' 18' ' ' ALA . 8.7 p30 -80.02 140.29 36.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.128 0.489 . . . . 0.0 111.07 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.571 ' O ' HG22 ' A' ' 20' ' ' THR . 0.8 OUTLIER -100.36 -44.39 11.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.366 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.455 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -50.25 -27.11 5.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.349 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.79 -20.76 16.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.313 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -83.0 -54.53 4.99 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 110.987 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 16' ' ' VAL . 6.4 t -45.6 -27.01 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.5 t -49.86 -40.08 41.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.88 0.371 . . . . 0.0 111.369 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.95 -35.48 8.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.358 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.0 m -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.308 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -111.29 31.28 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.934 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 11.8 mttp . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 1.0 110.874 -179.986 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.652 ' HA ' HG22 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.814 0.34 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.553 ' N ' HG23 ' A' ' 16' ' ' VAL . 12.2 p -100.93 -24.07 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -56.51 -30.77 63.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.816 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -100.56 26.69 6.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.422 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 21.1 t -89.53 113.73 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.656 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.59 35.07 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.101 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.861 HD22 ' HB3' ' A' ' 10' ' ' CYS . 3.7 tt -138.88 91.75 11.52 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.771 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.77 54.78 4.13 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.535 2.157 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.2 tttt 174.22 39.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.731 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.861 ' HB3' HD22 ' A' ' 7' ' ' LEU . 17.8 p -107.02 -40.58 5.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.66 -175.67 2.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -117.1 -38.28 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -121.5 29.2 7.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.251 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 58.24 50.87 9.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.082 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -79.96 144.01 33.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.807 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.652 HG22 ' HA ' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.32 -44.23 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.437 -179.309 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -72.77 -22.48 60.83 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.325 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.46 10.47 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.717 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -93.88 -56.23 2.95 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.813 0.339 . . . . 0.0 110.903 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.9 t -45.84 -26.88 0.74 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.798 0.296 . . . . 0.0 111.798 -179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.0 t -49.97 -40.5 44.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.908 0.385 . . . . 0.0 111.429 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -104.64 -33.12 8.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.281 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.545 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -88.82 177.35 6.73 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.226 -179.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -142.98 33.61 1.37 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.5 mttp . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.255 -0.878 . . . . 1.0 110.941 -179.995 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.002 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.79 0.329 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.96 30.49 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.636 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -95.31 -41.73 8.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.649 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -98.56 25.45 6.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.754 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.445 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 41.4 t -80.66 97.9 7.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.742 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.542 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.97 35.07 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.251 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.566 HD13 ' HB3' ' A' ' 10' ' ' CYS . 0.2 OUTLIER -108.47 119.73 48.59 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.762 179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.42 -28.15 34.34 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.429 2.086 . . . . 0.0 112.282 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -168.26 86.87 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.844 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.566 ' HB3' HD13 ' A' ' 7' ' ' LEU . 30.4 p -95.41 -40.93 9.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.83 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB1' ' OD1' ' A' ' 15' ' ' ASN . . . -122.64 -40.92 2.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.81 29.94 10.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.139 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.572 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -139.13 14.81 2.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.402 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.0 25.61 3.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.685 0.279 . . . . 0.0 111.475 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.572 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -85.16 135.54 33.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 110.917 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 1.002 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.42 -44.49 11.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.413 -179.257 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.451 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -71.75 -25.22 61.96 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.271 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . . . -103.88 6.88 36.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.784 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.595 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -91.33 -54.87 3.74 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.478 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.19 -26.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.9 t -49.6 -40.61 39.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.823 0.345 . . . . 0.0 111.371 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.595 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.0 OUTLIER -103.62 -35.48 8.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.213 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.529 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -86.24 178.2 7.26 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.173 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -156.83 32.3 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.1 mttp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.253 -0.88 . . . . 1.0 110.942 179.968 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.566 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.796 0.332 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.602 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.7 p 44.25 30.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.594 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -103.64 -44.64 5.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.614 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -98.65 23.37 8.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.823 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.432 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 30.7 t -72.94 78.88 1.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.72 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.7 pt -60.46 -29.88 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.14 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.0 OUTLIER -57.03 109.42 1.71 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.895 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.2 -47.48 26.6 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.379 2.053 . . . . 0.0 112.318 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.447 ' C ' HD22 ' A' ' 7' ' ' LEU . 10.1 tttt -133.18 97.32 3.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.998 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' HB3' HD22 ' A' ' 7' ' ' LEU . 28.7 p -113.79 -40.5 3.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.651 ' HB2' ' HE1' ' A' ' 22' ' ' HIS . . . -136.17 -46.92 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.98 47.04 4.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.213 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -136.92 13.13 3.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.488 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.83 24.68 3.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.511 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.487 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 5.2 p30 -106.15 142.24 36.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.066 0.46 . . . . 0.0 110.869 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.566 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.34 -45.38 11.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.397 -179.289 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.458 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -62.17 -25.23 67.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.026 -0.533 . . . . 0.0 111.182 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . . . -99.65 -10.71 21.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.604 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.589 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -84.03 -55.98 3.92 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.853 0.358 . . . . 0.0 110.979 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.488 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 8.8 t -45.94 -26.89 0.78 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' ALA . 8.2 t -49.44 -40.41 36.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.819 0.343 . . . . 0.0 111.407 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.651 ' HE1' ' HB2' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -104.09 -35.21 8.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.247 -179.691 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.3 m -86.24 126.09 34.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.139 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -97.09 39.28 1.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.934 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.228 -0.892 . . . . 1.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.909 ' HB3' ' CE1' ' A' ' 4' ' ' TYR . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.54 ' N ' HG23 ' A' ' 16' ' ' VAL . 11.0 p -94.12 -28.76 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.056 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -58.61 -30.38 67.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.909 ' CE1' ' HB3' ' A' ' 1' ' ' ALA . 1.7 p90 -125.76 23.07 7.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -62.19 93.0 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.369 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 7' ' ' LEU . 2.7 pp -57.3 -42.96 81.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.375 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.814 HD22 ' HB3' ' A' ' 10' ' ' CYS . 1.5 tt -53.47 107.81 0.95 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.108 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.8 118.89 5.86 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.488 2.125 . . . . 0.0 112.344 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp 59.91 64.52 1.26 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.987 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.814 ' HB3' HD22 ' A' ' 7' ' ' LEU . 31.3 p -89.87 -30.54 17.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.818 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.563 ' HB2' ' CE1' ' A' ' 22' ' ' HIS . . . -154.06 -45.84 0.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.97 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 63.26 66.28 0.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.163 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.67 ' HB3' ' OD1' ' A' ' 15' ' ' ASN . . . -138.92 14.32 2.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.395 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.31 23.33 4.26 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.618 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.67 ' OD1' ' HB3' ' A' ' 13' ' ' ALA . 2.0 p30 -117.39 140.76 49.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.154 0.502 . . . . 0.0 110.99 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.54 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.8 OUTLIER -100.44 -45.88 11.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.25 -179.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -59.07 -28.38 66.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.619 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.51 -17.81 22.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.348 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.603 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -78.89 -50.64 10.89 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.851 0.358 . . . . 0.0 110.813 -179.883 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.481 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 4.5 t -46.96 -26.01 0.91 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.2 t -51.38 -39.68 57.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.826 0.346 . . . . 0.0 111.37 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.603 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.13 -35.53 8.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.195 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.3 m -86.75 174.21 8.97 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.144 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -140.73 45.53 1.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.8 mttp . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.189 -0.91 . . . . 1.0 110.953 179.947 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.806 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.792 0.329 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.604 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.6 p 43.97 30.32 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.721 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.25 -59.82 1.73 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -74.09 -18.89 60.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.857 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.7 t -50.38 130.13 22.91 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.017 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.4 pt -138.76 29.69 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.113 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 8' ' ' PRO . 8.4 tt -83.67 137.61 41.32 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.756 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.637 ' N ' HD23 ' A' ' 7' ' ' LEU . 49.2 Cg_exo -55.65 85.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.437 2.091 . . . . 0.0 112.359 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.8 tttt 55.34 83.26 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.116 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' HB3' HD22 ' A' ' 7' ' ' LEU . 21.3 p -90.96 -40.48 11.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.842 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -103.25 -167.03 1.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.046 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -112.63 -46.36 3.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -120.32 31.54 6.43 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.171 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 59.26 53.59 5.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -79.81 145.17 32.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.863 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.806 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.3 -43.77 11.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.344 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -74.89 -18.25 60.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.411 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 21' ' ' THR . . . -114.21 11.3 17.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.781 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -90.78 -55.64 3.49 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.81 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.479 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 3.5 t -46.32 -26.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.74 0.305 . . . . 0.0 111.7 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 18' ' ' ALA . 10.5 t -49.92 -40.6 43.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.836 0.35 . . . . 0.0 111.303 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.597 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.72 -34.66 8.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.167 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.6 m -87.14 179.34 6.67 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.272 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -146.94 31.94 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 tttp . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.877 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.671 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.856 0.36 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 2' ' ' VAL . 11.0 p 44.24 30.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.734 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -89.74 -44.32 10.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.662 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -98.72 26.59 5.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.73 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.42 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 45.0 t -73.78 66.82 1.13 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -60.82 -23.0 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.437 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.494 HD22 ' CA ' ' A' ' 10' ' ' CYS . 0.5 OUTLIER -54.56 138.5 60.65 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 -179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' HD23 ' A' ' 7' ' ' LEU . 74.5 Cg_endo -75.05 87.35 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.57 2.18 . . . . 0.0 112.371 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 15.6 mttp 59.14 65.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.915 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' CA ' HD22 ' A' ' 7' ' ' LEU . 30.2 p -60.74 -40.28 91.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.54 -47.18 0.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.042 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 62.34 71.85 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.233 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.454 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -154.6 25.86 0.45 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.085 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 54.53 23.88 4.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.427 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 8.8 p30 -99.55 125.46 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.299 0.571 . . . . 0.0 110.831 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.671 HG21 ' HB1' ' A' ' 1' ' ' ALA . 1.4 t -100.29 -63.76 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.038 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -54.07 -26.59 27.68 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.594 ' O ' HG22 ' A' ' 21' ' ' THR . . . -93.58 -12.07 30.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.518 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.601 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.96 -55.23 4.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.831 0.348 . . . . 0.0 110.865 -179.823 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.49 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 2.8 t -45.65 -26.9 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.594 HG22 ' O ' ' A' ' 18' ' ' ALA . 7.3 t -49.21 -40.52 33.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.369 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.601 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 0.9 OUTLIER -103.63 -35.6 8.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 0.0 111.221 -179.745 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.9 m -85.99 128.6 34.89 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.185 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -98.71 31.57 2.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.894 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.209 -0.9 . . . . 1.0 110.883 -179.986 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.815 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.8 0.333 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 2' ' ' VAL . 12.0 p 44.01 30.45 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.573 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -107.7 -56.14 2.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.586 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -75.76 -20.05 58.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.915 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 35.7 t -51.82 109.81 0.4 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.034 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.5 pt -97.72 30.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.053 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.63 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.3 tt -121.55 93.18 48.77 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.14 53.18 4.11 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.529 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tttm 177.39 38.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.765 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.63 ' HB3' HD22 ' A' ' 7' ' ' LEU . 20.6 p -106.84 -41.3 5.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.763 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -96.06 -168.11 1.7 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.139 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -105.06 -39.31 6.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -145.35 48.57 1.27 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 46.0 10.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.09 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -79.94 143.75 33.92 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.906 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -100.27 -43.87 11.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.346 -179.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -73.83 -21.89 59.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.327 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' HG22 ' A' ' 21' ' ' THR . . . -108.54 9.49 27.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.46 -0.337 . . . . 0.0 111.667 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.593 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -91.89 -56.42 3.09 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.779 0.323 . . . . 0.0 110.814 179.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.495 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 9.8 t -46.12 -26.91 0.84 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.425 HG22 ' O ' ' A' ' 18' ' ' ALA . 9.9 t -50.11 -40.4 45.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.362 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.593 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.43 -33.52 8.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.25 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.538 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.5 m -88.4 179.9 6.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.211 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -137.71 31.79 2.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.897 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.2 tttt . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.19 -0.909 . . . . 1.0 110.89 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.746 0.308 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.609 ' N ' HG23 ' A' ' 16' ' ' VAL . 10.8 p -79.47 -34.35 15.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.878 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -68.17 -31.5 71.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.666 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -100.28 22.17 11.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.984 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 17.2 t -85.38 110.22 18.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.596 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.533 ' O ' HD12 ' A' ' 6' ' ' ILE . 1.7 pp -96.14 34.97 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.18 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 10' ' ' CYS . 4.0 tt -133.95 82.42 49.15 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.806 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.73 57.09 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.901 2.401 . . . . 0.0 112.345 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 172.99 38.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.676 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' CD2' ' A' ' 22' ' ' HIS . 17.8 p -108.97 -40.32 5.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.921 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -137.88 -175.11 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.052 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.43 36.4 0.28 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.161 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HB3' ' ND2' ' A' ' 15' ' ' ASN . . . -133.99 10.27 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.537 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 52.57 25.49 3.69 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.805 0.336 . . . . 0.0 111.369 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.551 ' ND2' ' HB3' ' A' ' 13' ' ' ALA . 6.8 p30 -104.18 151.22 23.6 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.16 0.505 . . . . 0.0 110.938 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.609 HG23 ' N ' ' A' ' 2' ' ' VAL . 0.9 OUTLIER -100.27 -45.38 11.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.294 -179.464 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' N ' ' CG1' ' A' ' 16' ' ' VAL . . . -54.97 -24.46 24.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.13 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 21' ' ' THR . . . -100.68 -17.82 16.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.383 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.602 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -82.43 -53.44 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.807 0.337 . . . . 0.0 110.856 -179.875 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.491 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.6 t -46.38 -26.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.7 t -51.23 -39.85 57.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.793 0.33 . . . . 0.0 111.366 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.602 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -104.18 -33.45 8.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.239 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.5 m -89.0 139.1 30.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.153 -179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -95.37 44.22 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.5 tptt . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.275 -0.869 . . . . 1.0 110.943 179.978 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.656 ' HA ' HG13 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.822 0.344 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' N ' HG22 ' A' ' 16' ' ' VAL . 9.9 p -94.56 -24.17 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.193 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -55.25 -32.31 62.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.779 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -101.82 24.75 9.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.923 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.416 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 19.0 t -82.5 102.33 11.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.597 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.3 pt -76.41 -4.86 6.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.57 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 10' ' ' CYS . 5.4 tt -106.06 92.79 6.94 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.863 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -77.3 53.64 4.35 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.585 2.19 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tttm 175.78 39.46 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.648 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.591 ' HB3' HD22 ' A' ' 7' ' ' LEU . 29.2 p -102.19 -40.8 6.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.52 -174.5 3.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.077 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.44 30.57 0.28 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.174 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -141.91 22.42 2.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.259 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 53.54 27.68 6.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.435 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.499 ' HB2' ' HB3' ' A' ' 18' ' ' ALA . 16.2 p30 -80.77 133.59 35.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.328 0.585 . . . . 0.0 110.944 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.656 HG13 ' HA ' ' A' ' 1' ' ' ALA . 1.4 t -100.15 -63.74 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.979 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.577 ' N ' HG12 ' A' ' 16' ' ' VAL . . . -55.81 -29.18 59.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.1 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.62 ' O ' HG22 ' A' ' 21' ' ' THR . . . -88.36 -9.9 51.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.442 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.612 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -81.83 -53.34 6.26 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.802 0.334 . . . . 0.0 110.784 -179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.494 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 5.1 t -46.3 -26.51 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 18' ' ' ALA . 6.5 t -50.88 -39.94 55.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 111.399 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.612 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.2 p-80 -103.97 -33.63 8.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.233 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.535 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 3.0 m -88.79 177.77 6.63 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.171 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -148.57 37.16 0.82 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.278 -0.868 . . . . 1.0 110.868 179.984 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.977 ' HB1' HG21 ' A' ' 16' ' ' VAL . . . . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 2' ' ' VAL . 10.7 p 44.04 30.36 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.603 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -84.14 -56.04 3.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.551 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -89.31 7.81 33.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.004 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.427 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 14.1 t -60.16 109.35 0.95 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.854 0.359 . . . . 0.0 110.791 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.8 pt -97.09 31.94 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.924 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 10' ' ' CYS . 1.4 tt -141.01 87.42 10.88 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.702 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.79 -26.8 75.0 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.511 2.141 . . . . 0.0 112.349 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.438 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -96.89 42.92 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.802 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.513 ' N ' HD22 ' A' ' 7' ' ' LEU . 15.4 p -106.67 -40.71 5.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.903 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.05 -166.52 1.32 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -104.17 -47.06 4.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.233 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -135.1 43.19 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.175 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.45 41.25 16.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.102 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -79.78 143.46 34.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.977 HG21 ' HB1' ' A' ' 1' ' ' ALA . 0.5 OUTLIER -100.25 -43.81 11.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.439 -179.248 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -74.47 59.0 0.79 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.018 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB2' ' O ' ' A' ' 17' ' ' ALA . . . 166.5 -31.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.824 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.61 ' O ' ' CD2' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -49.99 -50.57 46.63 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.161 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.47 ' N ' ' CD2' ' A' ' 19' ' ' HIS . 6.5 t -46.77 -26.13 0.88 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 18' ' ' ALA . 3.5 t -51.95 -38.96 58.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.776 0.322 . . . . 0.0 111.489 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.61 ' CD2' ' O ' ' A' ' 19' ' ' HIS . 1.1 p-80 -103.91 -33.92 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.226 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' CB ' ' CE1' ' A' ' 19' ' ' HIS . 2.2 m -88.9 176.45 7.03 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.214 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -152.65 34.34 0.5 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.5 mttp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.271 -0.871 . . . . 1.0 110.881 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_